{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1175333, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:15:28Z", "timestamp": 1574482528483}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 4, 1]], "date-time": "2011-04-01T00:00:00Z", "timestamp": 1301616000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Oncology"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1016/j.clon.2010.11.005", "type": "journal-article", "created": {"date-parts": [[2010, 12, 5]], "date-time": "2010-12-05T09:30:07Z", "timestamp": 1291541407000}, "page": "209-215", "source": "Crossref", "is-referenced-by-count": 12, "title": ["A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer"], "prefix": "10.1016", "volume": "23", "author": [{"given": "M.", "family": "Beresford", "sequence": "first", "affiliation": []}, {"given": "I.", "family": "Tumur", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Chakrabarti", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Barden", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Rao", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Makris", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0936655510004516?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0936655510004516?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 6]], "date-time": "2019-06-06T20:46:32Z", "timestamp": 1559853992000}, "score": 92.07598, "issued": {"date-parts": [[2011, 4]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "3"}, "alternative-id": ["S0936655510004516"], "URL": "http://dx.doi.org/10.1016/j.clon.2010.11.005", "ISSN": ["0936-6555"], "issn-type": [{"value": "0936-6555", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:54:54Z", "timestamp": 1574286894543}, "reference-count": 8, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 8, 1]], "date-time": "2007-08-01T00:00:00Z", "timestamp": 1185926400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Breast"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1016/j.breast.2007.02.002", "type": "journal-article", "created": {"date-parts": [[2007, 4, 7]], "date-time": "2007-04-07T11:17:16Z", "timestamp": 1175944636000}, "page": "436-439", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer"], "prefix": "10.1016", "volume": "16", "author": [{"given": "Y.S.", "family": "Chin", "sequence": "first", "affiliation": []}, {"given": "M.J.", "family": "Beresford", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Ravichandran", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Makris", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Breast"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0960977607000458?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0960977607000458?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 10, 24]], "date-time": "2019-10-24T15:05:14Z", "timestamp": 1571929514000}, "score": 60.17366, "issued": {"date-parts": [[2007, 8]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "4"}, "alternative-id": ["S0960977607000458"], "URL": "http://dx.doi.org/10.1016/j.breast.2007.02.002", "ISSN": ["0960-9776"], "issn-type": [{"value": "0960-9776", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:27:08Z", "timestamp": 1574152028405}, "reference-count": 74, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1994, 1, 1]], "date-time": "1994-01-01T00:00:00Z", "timestamp": 757382400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Tr"], "published-print": {"date-parts": [[1994]]}, "DOI": "10.1007/bf00682740", "type": "journal-article", "created": {"date-parts": [[2004, 11, 28]], "date-time": "2004-11-28T15:57:19Z", "timestamp": 1101657439000}, "page": "43-55", "source": "Crossref", "is-referenced-by-count": 51, "title": ["Aromatase inhibitors ? mechanisms for non-steroidal inhibitors"], "prefix": "10.1007", "volume": "30", "author": [{"given": "Hugo Vanden", "family": "Bossche", "sequence": "first", "affiliation": []}, {"given": "Henri", "family": "Moereels", "sequence": "additional", "affiliation": []}, {"given": "Luc M. H.", "family": "Koymans", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "CR1", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1016/0960-0760(92)90320-I", "volume": "43", "author": "ER Simpson", "year": "1992", "unstructured": "Simpson ER, Kilgore MW, Mahendroo MS, Means GD, Corbin CJ, Mendelson CR: Regulation of human aromatase cytochrome P450 gene expression. J Steroid Biochem Mol Biol 43:923?930, 1992", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR2", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1021/ja00212a043", "volume": "110", "author": "PA Cole", "year": "1988", "unstructured": "Cole PA, Robinson CH: A peroxide model for placental aromatase. J Am Chem Soc 110:1284?1285, 1988", "journal-title": "J Am Chem Soc"}, {"key": "CR3", "first-page": "11939", "volume": "266", "author": "S Graham-Lorence", "year": "1991", "unstructured": "Graham-Lorence S, Khalil MW, Lorence MC, Mendelson CR, Simpson ER: Structure-function relationships of human aromatase cytochrome P-450 using molecular modeling and site-directed mutagenesis. J Biol Chem 266:11939?11946, 1991", "journal-title": "J Biol Chem"}, {"key": "CR4", "first-page": "16358", "volume": "263", "author": "MJ McPhaul", "year": "1988", "unstructured": "McPhaul MJ, Noble JF, Simpson ER, Mendelson CR, Wilson JD: The expression of a functional cDNA encoding the chicken cytochrome P450 Arom (aromatase) that catalyses the formation of estrogen from androgen. J Biol Chem 263:16358?16363, 1988", "journal-title": "J Biol Chem"}, {"key": "CR5", "doi-asserted-by": "crossref", "first-page": "8948", "DOI": "10.1073/pnas.85.23.8948", "volume": "85", "author": "CJ Corbin", "year": "1988", "unstructured": "Corbin CJ, Graham-Lorence S, McPhaul MJ, Mason JI, Mendelson CR, Simpson ER: Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85:8948?8952, 1988", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "CR6", "doi-asserted-by": "crossref", "first-page": "1477", "DOI": "10.1210/mend-3-9-1477", "volume": "3", "author": "D Pompon", "year": "1989", "unstructured": "Pompon D, Liu RY-K, Besman MJ, Wang PL, Shively JE, Chen S: Expression of human placental aromatase inSaccharomyces cerevisiae. Mol Endocrinol 3:1477?1487, 1989", "journal-title": "Mol Endocrinol"}, {"key": "CR7", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1677/joe.0.0710077", "volume": "71", "author": "KP McNatty", "year": "1976", "unstructured": "McNatty KP, Baird DT, Boltan A, Chambers P, Corker CS, McLean H: Concentration of oestrogens and androgens in human ovarian follicular fluid throughout the menstrual cycle. J Endocrinol 71:77?85, 1976", "journal-title": "J Endocrinol"}, {"key": "CR8", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1530/jrf.0.0850163", "volume": "85", "author": "H Sasano", "year": "1989", "unstructured": "Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SC: Immunolocalization of aromatase, 17?-hydroxylase and side-chain cleavage cytochromes P450 in human ovary. J Reprod Fertil 85:163?169, 1989", "journal-title": "J Reprod Fertil"}, {"key": "CR9", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1016/0039-128X(87)90040-7", "volume": "50", "author": "RJ Santen", "year": "1987", "unstructured": "Santen RJ: Potential clinical use of new aromatase inhibitors. Steroids 50:575?593, 1987", "journal-title": "Steroids"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1016/0002-9378(78)90288-0", "volume": "130", "author": "CD Edman", "year": "1978", "unstructured": "Edman CD, MacDonald PC: Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 130:456?461, 1978", "journal-title": "Am J Obstet Gynecol"}, {"key": "CR11", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1016/0039-128X(87)90036-5", "volume": "50", "author": "DW Killinger", "year": "1987", "unstructured": "Killinger DW, Perel E, Daniilescu D, Kharlip L, Martin E: Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation. Steroids 50: 523?536, 1987", "journal-title": "Steroids"}, {"key": "CR12", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1016/0039-128X(87)90037-7", "volume": "50", "author": "WR Miller", "year": "1987", "unstructured": "Miller WR, O'Neil J: The importance of local synthesis of estrogen within the breast. Steroids 50: 537?548, 1987", "journal-title": "Steroids"}, {"key": "CR13", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1111/j.1749-6632.1990.tb34296.x", "volume": "595", "author": "VHT James", "year": "1990", "unstructured": "James VHT, Reed MJ, Lai LC, Ghilchik MW, Tait GH, Newton CJ, Coldham NG: Regulation of estrogen concentrations in human breast tissues. Ann NY Acad Sci 595:227?235, 1990", "journal-title": "Ann NY Acad Sci"}, {"key": "CR14", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1016/0277-5379(86)90121-5", "volume": "22", "author": "A Vermeulen", "year": "1986", "unstructured": "Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC: Aromatase, 17\u00df-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur J Cancer Clin Oncol 22:515?525, 1986", "journal-title": "Eur J Cancer Clin Oncol"}, {"key": "CR15", "doi-asserted-by": "crossref", "first-page": "317", "DOI": "10.1016/0960-0760(90)90480-9", "volume": "37", "author": "WR Miller", "year": "1990", "unstructured": "Miller WR, O'Neil J: The significance of steroid metabolism in human cancer. J Steroid Biochem Mol Biol 37:317?325, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR16", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1016/0960-0760(91)90028-4", "volume": "39", "author": "JHH Thijssen", "year": "1991", "unstructured": "Thijssen JHH, Blankenstein MA, Donker GH, Daroszewski: Endogenous steroid hormones and local aromatase activity in the breast. J Steroid Biochem Mol Biol 39:799?804, 1991", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR17", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1016/0960-0760(91)90027-3", "volume": "39", "author": "MJ Reed", "year": "1991", "unstructured": "Reed MJ, Singh A, Ghilchik MW, Coldham NG, Purohit A: Regulation of oestradiol 17\u00df-hydroxysteroid dehydrogenase in breast tissues: the role of growth factors. J Steroid Biochem Mol Biol 39:791?798, 1991", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR18", "author": "IM Jackson", "first-page": "87", "year": "1987", "unstructured": "Jackson IM, Lowery C: Clinical uses of antiestrogens.In: Furr BJA, Wakeling AE (eds) Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Balli\u00e8re Tindall, London, 1987, p 87?105", "volume-title": "Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action"}, {"key": "CR19", "author": "A Manni", "first-page": "271", "year": "1987", "unstructured": "Manni A, Santen RJ: Clinical uses of aromatase inhibitors.In: Furr BJA, Wakeling AE (eds) Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Balli\u00e8re Tindall, London, 1987, p 271?287", "volume-title": "Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action"}, {"key": "CR20", "author": "L Banting", "first-page": "253", "year": "1989", "unstructured": "Banting L, Nichols PJ, Shaw MA, Smith HJ: Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer.In: Ellis GP, West GB (eds) Progress in Medicinal Chemistry. Elsevier Science Publishers, Amsterdam, 1989, vol 26, p 253?298", "volume-title": "Progress in Medicinal Chemistry"}, {"key": "CR21", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/0960-0760(90)90390-7", "volume": "37", "author": "WR Miller", "year": "1990", "unstructured": "Miller WR: Endocrine treatment for breast cancers: biological rationale and current progress. J Steroid Biochem Mol Biol 37:467?480, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR22", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1111/j.1749-6632.1990.tb34305.x", "volume": "595", "author": "RI Nicholson", "year": "1990", "unstructured": "Nicholson RI, Walker KJ, Bouzubar N, Wills RJ, Gee JMW, Rushmere NK, Davies P: Estrogen deprivation in breast cancer. Ann NY Acad Sci 595:316?327, 1990", "journal-title": "Ann NY Acad Sci"}, {"key": "CR23", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0960-0760(90)90479-5", "volume": "37", "author": "RB Dickson", "year": "1990", "unstructured": "Dickson RB, Thompson EW, Lippman ME: Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol Biol 37:305?316, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR24", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/0960-0760(91)90190-G", "volume": "40", "author": "A Brodie", "year": "1991", "unstructured": "Brodie A: Aromatase and its inhibitors ? an overview. J Steroid Biochem Mol Biol 40:255?261, 1991", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR25", "doi-asserted-by": "crossref", "first-page": "805", "DOI": "10.1016/0960-0760(91)90029-5", "volume": "39", "author": "M Dowsett", "year": "1991", "unstructured": "Dowsett M: Inhibitors of steroidogenic enzymes for the treatment of breast cancer. J Steroid Biochem Mol Biol 39:805?809, 1991", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR26", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1177/030006059202000401", "volume": "20", "author": "N P\u00e9rez", "year": "1992", "unstructured": "P\u00e9rez N, Borja J: Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancers. J Intern Med Res 20:303?312, 1992", "journal-title": "J Intern Med Res"}, {"key": "CR27", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/0960-0760(90)90483-2", "volume": "37", "author": "JR Pasqualini", "year": "1990", "unstructured": "Pasqualini JR, Giambiagi N, Gelly C, Chetrite G: Antiestrogen action in mammary cancer and in fetal cells. J Steroid Biochem Mol Biol 37:343?348, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "suppl II", "key": "CR28", "first-page": "3", "volume": "41", "author": "C Nadjafi", "year": "1986", "unstructured": "Nadjafi C: Aminoglutethimide chemistry, pharmacokinetics, pharmacology and mechanism of action. Acta Clin Belg 41 (suppl II): 3?11, 1986", "journal-title": "Acta Clin Belg"}, {"key": "CR29", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1210/endo-101-1-89", "volume": "101", "author": "VI Uzgiris", "year": "1977", "unstructured": "Uzgiris VI, Whipple CA, Salhanick HA: Stereoselective inhibition of cholesterol side chain cleavage by enantiomers of aminoglutethimide. Endocrinology 101: 89?92, 1977", "journal-title": "Endocrinology"}, {"key": "CR30", "doi-asserted-by": "crossref", "first-page": "592", "DOI": "10.1016/0003-9861(87)90142-1", "volume": "254", "author": "B Walther", "year": "1987", "unstructured": "Walther B, Ghersi-Egea JF, Minn A, Siest G: Brain mitochondrial cytochrome P450scc: spectral and catalytic properties. Arch Biochem Biophys 254:592?596, 1987", "journal-title": "Arch Biochem Biophys"}, {"key": "CR31", "doi-asserted-by": "crossref", "first-page": "1390", "DOI": "10.1210/endo-121-4-1390", "volume": "121", "author": "M Georgiou", "year": "1987", "unstructured": "Georgiou M, Perkins LM, Payne AH: Steroid synthesis-dependent oxygen-mediated damage of mitochondrial and microsomal cytochrome P450 enzymes in rat Leydig cell cultures. Endocrinology 121:1390?1399, 1987", "journal-title": "Endocrinology"}, {"key": "CR32", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1210/jcem-49-4-631", "volume": "49", "author": "RJ Santen", "year": "1979", "unstructured": "Santen RJ, Cohn N, Misbin R, Samojlik E, Foltz E: Acute effects of aminoglutethimide on testicular steroidogenesis in normal men. J Clin Endocrinol Metab 49:631?634, 1979", "journal-title": "J Clin Endocrinol Metab"}, {"key": "CR33", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1002/j.1875-9114.1981.tb03557.x", "volume": "1", "author": "RJ Santen", "year": "1981", "unstructured": "Santen RJ, Misbin RI: Aminoglutethimide: review of pharmacology and clinical uses. Pharmacotherapy 1:95?120, 1981", "journal-title": "Pharmacotherapy"}, {"key": "CR34", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1530/acta.0.0800517", "volume": "80", "author": "Y Touitou", "year": "1975", "unstructured": "Touitou Y, Bogdan A, Legrand JC, Desgrez P: Aminoglutethimide and glutethimide: effects on 18-hydroxycorticosterone biosynthesis by human and sheep adrenalsin vitro. Acta Endocrinol 80:517?526, 1975", "journal-title": "Acta Endocrinol"}, {"key": "CR35", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1210/jcem-27-4-473", "volume": "27", "author": "RN Dexter", "year": "1967", "unstructured": "Dexter RN, Fishman LM, Ney RL, Liddle GW: Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanisms of action. J Clin Endocrinol Metab 27:473?480, 1967", "journal-title": "J Clin Endocrinol Metab"}, {"key": "CR36", "first-page": "5373", "volume": "249", "author": "EA Thompson", "year": "1974", "unstructured": "Thompson EA, Siiteri PK: The involvement of human placental microsomal cytochrome P450 in aromatization. J Biol Chem 249:5373?5378, 1974", "journal-title": "J Biol Chem"}, {"issue": "Suppl 2", "key": "CR37", "first-page": "3315S", "volume": "42", "author": "HA Salhanick", "year": "1982", "unstructured": "Salhanick HA: Basic studies on aminoglutethimide. Cancer Res 42 (Suppl 2):3315S-3321S, 1982", "journal-title": "Cancer Res"}, {"key": "CR38", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1021/jm00380a009", "volume": "28", "author": "AB Foster", "year": "1985", "unstructured": "Foster AB, Jarman M, Leung C-S, Rowlands MG, Taylor GN, Plevey RG, Sampson P: Analogues of aminoglutethimide: selective inhibition of aromatase. J Med Chem 28:200?204, 1985", "journal-title": "J Med Chem"}, {"key": "CR39", "doi-asserted-by": "crossref", "first-page": "1550", "DOI": "10.1021/jm00392a004", "volume": "30", "author": "CS Leung", "year": "1987", "unstructured": "Leung CS, Rowlands MG, Jorman M, Foster AB, Griggs LS, Wilman DEV: Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-diones as selective inhibitors of aromatase derivatives with variable 1-alkyl and 3-alkyl substituents. J Med Chem 30:1550?1554, 1987", "journal-title": "J Med Chem"}, {"key": "CR40", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1210/edrv-11-2-221", "volume": "11", "author": "RJ Santen", "year": "1990", "unstructured": "Santen RJ, Manni A, Harvey H, Redmond C: Endocrine treatment of breast cancer in women. Endocr Rev 11:221?265, 1990", "journal-title": "Endocr Rev"}, {"key": "CR41", "doi-asserted-by": "crossref", "first-page": "3699", "DOI": "10.1021/jm00098a016", "volume": "35", "author": "R McCague", "year": "1992", "unstructured": "McCague R, Rowlands MG: Conformational analysis of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione (rogletimide) and discovery of potent 5-alkyl derivatives. J Med Chem 35:3699?3704, 1992", "journal-title": "J Med Chem"}, {"key": "CR42", "doi-asserted-by": "crossref", "first-page": "2673", "DOI": "10.1021/jm00171a052", "volume": "33", "author": "CA Laughton", "year": "1990", "unstructured": "Laughton CA, McKenna R, Neidle S, Jarman M, McCague R, Rowlands MG: Crystallographic and molecular modeling studies on 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione and its butyl analogue, inhibitors of mammalian aromatase. Comparison with natural substrates: prediction of enantioselectivity forN-alkyl derivatives. J Med Chem 33:2673?2679, 1990", "journal-title": "J Med Chem"}, {"key": "CR43", "first-page": "1363", "volume": "29", "author": "RW Hartmann", "year": "1986", "unstructured": "Hartmann RW, Batzl C: Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones. J Med Chem 29:1363?1369, 1986", "journal-title": "J Med Chem"}, {"key": "CR44", "doi-asserted-by": "crossref", "first-page": "2210", "DOI": "10.1021/jm00090a010", "volume": "35", "author": "RW Hartmann", "year": "1992", "unstructured": "Hartmann RW, Batzl C, Pongratz TM, Mannschreck A: Synthesis and aromatase inhibition of 3-cycloalkyl-substituted 3-(4-aminophenyl)piperidine-2,6-diones. J Med Chem 35:2210?2214, 1992", "journal-title": "J Med Chem"}, {"key": "CR45", "doi-asserted-by": "crossref", "first-page": "2128", "DOI": "10.1210/endo-114-6-2128", "volume": "114", "author": "JT Kellis", "year": "1984", "unstructured": "Kellis JT, Vickery LE: Inhibition of estrogen synthase (aromatase) by 4-cyclohexylaniline. Endocrinology 114:2128?2137, 1984", "journal-title": "Endocrinology"}, {"key": "CR46", "author": "H Bossche Vanden", "first-page": "179", "year": "1993", "unstructured": "Vanden Bossche H, Marichal P, Moereels H: Molecular mechanisms of antifungal activity and fungal resistance: focus on inhibitors of ergosterol biosynthesis.In: Maresca B, Kobayashi GS, Yamaguchi H (eds) Molecular Biology and its Application in Medical Mycology. Springer-Verlag, Berlin, 1993, p 179?197", "volume-title": "Molecular Biology and its Application in Medical Mycology"}, {"key": "CR47", "doi-asserted-by": "crossref", "first-page": "1193", "DOI": "10.1016/S0002-9378(12)90726-7", "volume": "165", "author": "H Bossche Vanden", "year": "1991", "unstructured": "Vanden Bossche H, Marichal P: Mode of action of anti-Candida drugs: Focus on terconazole and other ergosterol biosynthesis inhibitors. Am J Obstet Gynecol 165:1193?1199, 1991", "journal-title": "Am J Obstet Gynecol"}, {"key": "CR48", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1016/0039-128X(83)90070-3", "volume": "50", "author": "JI Mason", "year": "1987", "unstructured": "Mason JI, Carr BR, Murray BA: Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation. Steroids 50:179?189, 1987", "journal-title": "Steroids"}, {"key": "CR49", "doi-asserted-by": "crossref", "first-page": "1003", "DOI": "10.1016/0960-0760(92)90328-G", "volume": "43", "author": "H Bossche Vanden", "year": "1992", "unstructured": "Vanden Bossche H: Inhibitors of P450-dependent steroid biosynthesis: from research to medical treatment. J Steroid Biochem Mol Biol 43:1003?1021, 1992", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR50", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/0039-128X(83)90068-5", "volume": "50", "author": "RE Steele", "year": "1987", "unstructured": "Steele RE, Mellor LB, Sawyer WK, Wasvary JM, Browne RE:In vitro andin vivo studies demonstrating potent and selective estrogen inhibition with the nonsteroidal aromatase inhibitor CGS16949A. Steroids 50:147?161, 1987", "journal-title": "Steroids"}, {"key": "CR51", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1016/0960-0760(90)90485-4", "volume": "37", "author": "AS Bhatnagar", "year": "1990", "unstructured": "Bhatnagar AS, H\u00e4usler A, Schieweck K, Browne LJ, Bowman R, Steele RE: Novel aromatase inhibitors. J Steroid Biochem Mol Biol 37:363?367, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR52", "doi-asserted-by": "crossref", "first-page": "725", "DOI": "10.1021/jm00106a038", "volume": "34", "author": "LJ Browne", "year": "1991", "unstructured": "Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnagar A: Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease. J Med Chem 34:725?736, 1991", "journal-title": "J Med Chem"}, {"key": "CR53", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1016/0960-0760(92)90295-T", "volume": "43", "author": "N Kadohama", "year": "1992", "unstructured": "Kadohama N, Yarborough C, Zhou D, Chen S, Osaw Y: Kinetic properties of aromatase mutants Pro 308 Phe, Asp 309 Asn, and Asp 309 Ala and their interactions with aromatase inhibitors. J Steroid Biochem Mol Biol 43:693?701, 1992", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR54", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1021/jm00062a012", "volume": "36", "author": "P Furet", "year": "1993", "unstructured": "Furet P, Batzl C, Bhatnagar A, Francotte E, Lang M: Aromatase inhibitors: synthesis, biological activity, and binding mode of azole type compounds. J Med Chem 36:1393?1400, 1993", "journal-title": "J Med Chem"}, {"key": "CR55", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1210/jcem-69-4-896", "volume": "69", "author": "SWJ Lamberts", "year": "1989", "unstructured": "Lamberts SWJ, Bruining HA, Marzouk H, Zuiderwijk J, Uitterlinden P, Blijd JJ, Hacking WHL, De Jong FH: The new aromatase inhibitor CGS-16949A suppresses aldosterone and cortisol production by human adrenal cellsin vitro. J Clin Metab 69:896?901, 1989", "journal-title": "J Clin Metab"}, {"key": "CR56", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1210/jcem-68-1-99", "volume": "68", "author": "RJ Santen", "year": "1989", "unstructured": "Santen RJ, Demers LM, Adlercreutz H, Harvey HA, Santner S, Sanders S, Lipton A: Inhibition of aromatase with CGS16949A in post-menopausal women. J Clin Endocrinol Metab 68:99?106, 1989", "journal-title": "J Clin Endocrinol Metab"}, {"key": "CR57", "first-page": "1162", "volume": "70", "author": "LM Demers", "year": "1990", "unstructured": "Demers LM, Melby JC, Wilson TE, Lipton A, Harvey HA, Santen RJ: The effects of CGS 16949A, an aromatase inhibitor, on adrenal mineralocorticoid biosynthesis. J Clin Endocrinol Metab 70:1162?1166, 1990", "journal-title": "J Clin Endocrinol Metab"}, {"key": "CR58", "doi-asserted-by": "crossref", "first-page": "1279", "DOI": "10.1002/1097-0142(19900315)65:6<1279::AID-CNCR2820650604>3.0.CO;2-3", "volume": "65", "author": "A Lipton", "year": "1990", "unstructured": "Lipton A, Harvey HA, Demers LM, Hanagan JR, Mulagha MT, Kochak GM, Fitzsimmons S, Sanders SI, Santen RJ: A phase I trial of CGS 16949A, a new aromatase inhibitor. Cancer 65:1279?1285, 1990", "journal-title": "Cancer"}, {"key": "CR59", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1111/j.1365-2265.1990.tb00906.x", "volume": "32", "author": "M Dowsett", "year": "1990", "unstructured": "Dowsett M, Stein RC, Mehta A, Coombes RC: Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients. Clin Endocrinol 32:623?634, 1990", "journal-title": "Clin Endocrinol"}, {"key": "CR60", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1200/JCO.1992.10.1.111", "volume": "10", "author": "JI Raats", "year": "1992", "unstructured": "Raats JI, Falkson G, Falkson HC: A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer. J Clin Oncol 10:111?116, 1992", "journal-title": "J Clin Oncol"}, {"key": "CR61", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1016/0960-0760(93)90281-Z", "volume": "44", "author": "JAA Geelen", "year": "1993", "unstructured": "Geelen JAA, Loozen HJJ, Deckers GH, De Leeuw R, Kloosterboer HJ, Lamberts SWJ: ORG 33201: a new highly selective orally active aromatase inhibitor. J Steroid Biochem Mol Biol 44:681?682, 1993", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR62", "doi-asserted-by": "crossref", "first-page": "1707", "DOI": "10.1016/0006-2952(90)90346-M", "volume": "40", "author": "H Bossche Vanden", "year": "1990", "unstructured": "Vanden Bossche H, Willemsens G, Roels I, Bellens D, Moereels H, Coene MC, LeJeune L, Lauwers W, Janssen PAJ: R 76 713 and enantiomers: selective, nonsteroidal inhibitors of the cytochrome P450-dependent estrogen synthesis. Biochem Pharmacol 40:1707?1718, 1990", "journal-title": "Biochem Pharmacol"}, {"key": "CR63", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1016/0039-128X(90)90027-9", "volume": "55", "author": "MDWG Krekels", "year": "1990", "unstructured": "Krekels MDWG, Wouters W, De Coster R: Aromatase inhibition by R 76 713: a kinetic analysis in rat ovarian homogenates. Steroids 55:69?73, 1990", "journal-title": "Steroids"}, {"key": "CR64", "doi-asserted-by": "crossref", "first-page": "781", "DOI": "10.1016/0022-4731(89)90453-6", "volume": "32", "author": "W Wouters", "year": "1989", "unstructured": "Wouters W, De Coster R, Krekels M, Van Dun J, Beerens D, Haelterman C, Raeymaekers A, Freyne E, Van Gelder J, Venet M, Janssen PAJ: R 76 713, a new specific non-steroidal aromatase inhibitor. J Steroid Biochem 32:781?788, 1989", "journal-title": "J Steroid Biochem"}, {"key": "CR65", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/0960-0760(90)90482-Z", "volume": "37", "author": "R Coster De", "year": "1990", "unstructured": "De Coster R, Wouters W, Bowden CR, Vanden Bossche H, Bruynseels J, Tuman RW, Van Ginckel R, Snoeck E, Van Peer A, Janssen PAJ: New nonsteroidal aromatase inhibitors: focus on R 76 713. J Steroid Biochem Mol Biol 37:335?341, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR66", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1016/0960-0760(91)90329-4", "volume": "38", "author": "MDWG Krekels", "year": "1991", "unstructured": "Krekels MDWG, Wouters W, De Coster R, Van Ginckel R, Leonaers A, Janssen PAJ: Aromatase in human choriocarcinoma JEG-3: inhibition by R 76 713 in cultured cells and in tumors grown in nude mice. J Steroid Biochem Mol Biol 38:415?422, 1991", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR67", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1016/0022-4731(90)90113-7", "volume": "36", "author": "W Wouters", "year": "1990", "unstructured": "Wouters W, De Coster R, Beerens D, Doolaege R, Guiwez JA, Van Camp K, Vanden Pas H, Van Herendael B: Potency and selectivity of the aromatase inhibitor R 76 713. A study of ovarian, adipose, stromal, testicular and adrenal cells. J Steroid Biochem 36:57?65, 1990", "journal-title": "J Steroid Biochem"}, {"key": "CR68", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/0167-4838(93)90181-P", "volume": "1163", "author": "N Kadohama", "year": "1993", "unstructured": "Kadohama N, Zhou D, Chen S, Osawa Y: Catalytic efficiency of expressed aromatase following sitedirected mutagenesis. Biochim Biophys Acta 1163: 195?200, 1993", "journal-title": "Biochim Biophys Acta"}, {"key": "CR69", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1042/bst0180010", "volume": "18", "author": "H Bossche Vanden", "year": "1990", "unstructured": "Vanden Bossche H, Willemsens G, Bellens D, Roels I, Janssen PAJ: From 14?-demethylase inhibitors in fungal cells to androgen and oestrogen biosynthesis inhibitors in mammalian cells. Biochem Soc Trans 18:10?13, 1990", "journal-title": "Biochem Soc Trans"}, {"key": "CR70", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1007/BF00125315", "volume": "4", "author": "H Moereels", "year": "1990", "unstructured": "Moereels H, De Bie L, Tollenaere JP: CGEMA and VGAP: a colour graphics editor for multiple alignment using a variable gap penalty. Application to the muscarinic acetylcholine receptor. J Comput Aided Mol Design 4:131?145, 1990", "journal-title": "J Comput Aided Mol Design"}, {"key": "CR71", "author": "M Dukes", "first-page": "14", "year": "1992", "unstructured": "Dukes M, Edwards PN, Large M, Smith IK, Frank R, Yatesj RA, Deberardinis M, Plourde PV: ICI D1033, a new, selective, non-steroidal aromatase inhibitor (Abstract). 3rd International Conference on Aromatase, Bologna, June 14?17, 1992", "volume-title": "ICI D1033, a new, selective, non-steroidal aromatase inhibitor (Abstract)"}, {"key": "CR72", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.1016/0960-0760(90)90460-3", "volume": "37", "author": "AS Bhatnagar", "year": "1990", "unstructured": "Bhatnagar AS, H\u00e4usler A, Schieweck K, Lang M, Bowman R: Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J Steroid Biochem Mol Biol 37:1021?1027, 1990", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR73", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1016/0960-0760(93)90270-7", "volume": "44", "author": "K Schiewick", "year": "1993", "unstructured": "Schiewick K, Bhatnagar AS, Batzl Ch, Lang M: Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. J Steroid Biochem Mol Biol 44:633?636, 1993", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "CR74", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/0960-0760(93)90245-R", "volume": "44", "author": "M Lang", "year": "1993", "unstructured": "Lang M, Batzl Ch, Furet P, Bowman R, H\u00e4usler A, Bhatnagar AS: Structure-activity relationships and binding model of novel aromatase inhibitors. J Steroid Biochem Mol Biol 44:421?428, 1993", "journal-title": "J Steroid Biochem Mol Biol"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF00682740.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF00682740/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF00682740", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 5]], "date-time": "2019-04-05T09:18:35Z", "timestamp": 1554455915000}, "score": 56.03428, "issued": {"date-parts": [[1994]]}, "references-count": 74, "journal-issue": {"published-print": {"date-parts": [[1994]]}, "issue": "1"}, "alternative-id": ["BF00682740"], "URL": "http://dx.doi.org/10.1007/bf00682740", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:19:46Z", "timestamp": 1574111986878}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1999, 4]]}, "DOI": "10.1023/a:1008368300827", "type": "journal-article", "created": {"date-parts": [[2002, 12, 22]], "date-time": "2002-12-22T14:41:38Z", "timestamp": 1040568098000}, "page": "377-384", "source": "Crossref", "is-referenced-by-count": 69, "title": ["The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer"], "prefix": "10.1093", "volume": "10", "author": [{"given": "A.", "family": "Hamilton", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Piccart", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[1999, 4]]}, "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/10/4/377/19477293/10-4-377.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T17:55:16Z", "timestamp": 1503424516000}, "score": 53.59743, "issued": {"date-parts": [[1999, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1999, 4]]}, "published-print": {"date-parts": [[1999, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1023/a:1008368300827", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T05:16:17Z", "timestamp": 1574745377884}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "suppl_6", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1093/annonc/mdw365.42", "type": "journal-article", "created": {"date-parts": [[2017, 2, 3]], "date-time": "2017-02-03T17:24:43Z", "timestamp": 1486142683000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Predictors of effectiveness of the use of steroidal aromatase inhibitors after progression on non-steroidal aromatase inhibitors in advanced breast cancer patients"], "prefix": "10.1093", "volume": "27", "author": [{"given": "M.M. Ulrich", "family": "de Menezes Pereira dos Santos", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Cardoso", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Sousa", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Esteves", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Brito", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Moreira", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2016, 10, 11]]}, "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/27/suppl_6/263P/19449435/mdw365.42.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 9]], "date-time": "2017-08-09T05:16:21Z", "timestamp": 1502255781000}, "score": 52.421406, "issued": {"date-parts": [[2016, 10]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 10, 11]]}, "published-print": {"date-parts": [[2016, 10]]}, "issue": "suppl_6"}, "URL": "http://dx.doi.org/10.1093/annonc/mdw365.42", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T10:18:39Z", "timestamp": 1575454719110}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2019, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs18-ot1-01-01", "type": "proceedings-article", "created": {"date-parts": [[2019, 5, 11]], "date-time": "2019-05-11T19:13:56Z", "timestamp": 1557602036000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract OT1-01-01: The NEO-LET-EXE-trial: An intra-patient cross-over trial to explore the \"lack of cross-resistance\" between steroidal and non-steroidal aromatase inhibitors"], "prefix": "10.1158", "author": [{"given": "N", "family": "Bahrami", "sequence": "first", "affiliation": []}, {"given": "T", "family": "Sauer", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Loeng", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Gravdehaug", "sequence": "additional", "affiliation": []}, {"given": "SS", "family": "Engebretsen", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "Aljabri", "sequence": "additional", "affiliation": []}, {"given": "V", "family": "Bemanian", "sequence": "additional", "affiliation": []}, {"given": "JC", "family": "Lindstr\u00f8m", "sequence": "additional", "affiliation": []}, {"given": "T", "family": "L\u00fcders", "sequence": "additional", "affiliation": []}, {"given": "VN", "family": "Kristensen", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Geisler", "sequence": "additional", "affiliation": []}], "member": "1086", "event": {"name": "Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas"}, "container-title": ["Ongoing Clinical Trials"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS18-OT1-01-01", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T19:37:56Z", "timestamp": 1558208276000}, "score": 51.703495, "issued": {"date-parts": [[2019, 2, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS18-OT1-01-01"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs18-ot1-01-01"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T14:02:25Z", "timestamp": 1575295345511}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 11, 1]], "date-time": "2013-11-01T00:00:00Z", "timestamp": 1383264000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Value in Health"], "published-print": {"date-parts": [[2013, 11]]}, "DOI": "10.1016/j.jval.2013.08.522", "type": "journal-article", "created": {"date-parts": [[2013, 10, 22]], "date-time": "2013-10-22T07:51:25Z", "timestamp": 1382428285000}, "page": "A414", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Economic Evaluation of Fulvestrant 500 Mg Versus Generic Non-Steroidal Aromatase Inhibitors in Patients with Advanced Breast Cancer in Norway"], "prefix": "10.1016", "volume": "16", "author": [{"given": "M.", "family": "Ekman", "sequence": "first", "affiliation": []}, {"given": "J.", "family": "Jacob", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Bj\u00f8rheim", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Value in Health"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1098301513024273?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1098301513024273?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 11]], "date-time": "2018-10-11T23:25:01Z", "timestamp": 1539300301000}, "score": 50.204002, "issued": {"date-parts": [[2013, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 11]]}, "issue": "7"}, "alternative-id": ["S1098301513024273"], "URL": "http://dx.doi.org/10.1016/j.jval.2013.08.522", "ISSN": ["1098-3015"], "issn-type": [{"value": "1098-3015", "type": "print"}], "subject": ["Public Health, Environmental and Occupational Health", "Health Policy"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:15:17Z", "timestamp": 1574118917120}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 1, 1]], "date-time": "1993-01-01T00:00:00Z", "timestamp": 725846400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[1993, 1]]}, "DOI": "10.1016/0959-8049(93)91079-z", "type": "journal-article", "created": {"date-parts": [[2004, 4, 17]], "date-time": "2004-04-17T23:13:19Z", "timestamp": 1082243599000}, "page": "S86", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Phase II study of the eortc breast group with vorozole (R 83842), a new non-steroidal aromatase inhibitor in metastatic breast cancer (MBC) \u2014 preliminary results"], "prefix": "10.1016", "volume": "29", "author": [{"given": "R.", "family": "Paridaens", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Piccart", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Nooy", "sequence": "additional", "affiliation": []}, {"given": "J.G.M.", "family": "Klijn", "sequence": "additional", "affiliation": []}, {"given": "R.D.", "family": "Rubens", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Beex", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Tomiak", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Van Vreckem", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Vinholes", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:095980499391079Z?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:095980499391079Z?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T06:54:00Z", "timestamp": 1550040840000}, "score": 44.776752, "issued": {"date-parts": [[1993, 1]]}, "references-count": 0, "alternative-id": ["095980499391079Z"], "URL": "http://dx.doi.org/10.1016/0959-8049(93)91079-z", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:24:25Z", "timestamp": 1574688265619}, "publisher-location": "Cham", "reference-count": 130, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319179711", "type": "print"}, {"value": "9783319179728", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-3-319-17972-8_12", "type": "book-chapter", "created": {"date-parts": [[2015, 4, 25]], "date-time": "2015-04-25T13:15:09Z", "timestamp": 1429967709000}, "page": "261-285", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Aromatase Inhibitors Beyond Breast Cancer: Endometrium Versus Breast Puzzle and Other Issues"], "prefix": "10.1007", "author": [{"given": "Lev M.", "family": "Berstein", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 4, 26]]}, "reference": [{"issue": "4", "key": "12_CR1", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1210/er.2008-0016", "volume": "30", "author": "RJ Santen", "year": "2009", "unstructured": "Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev. 2009;30(4):343\u201375.", "journal-title": "Endocr Rev"}, {"key": "12_CR2", "unstructured": "Scientific conclusions and grounds for amendment of the summary of product characteristics, labelling and package leaflet presented by the European Medicines Agency, Annex II, 2012. \n                  http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Femara_30/WC500128492.pdf\n                  \n                ."}, {"issue": "1", "key": "12_CR3", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1016/j.clbc.2013.09.001", "volume": "14", "author": "KL Bradley", "year": "2014", "unstructured": "Bradley KL, Tyldesley S, Speers CH, Woods R, Villa D. Contemporary systemic therapy for male breast cancer. Clin Breast Cancer. 2014;14(1):31\u20139.", "journal-title": "Clin Breast Cancer"}, {"issue": "11", "key": "12_CR4", "doi-asserted-by": "crossref", "first-page": "2259", "DOI": "10.1038/bjc.2013.255", "volume": "108", "author": "F Zagouri", "year": "2013", "unstructured": "Zagouri F, Sergentanis TN, Koutoulidis V, Sparber C, Steger GG, Dubsky P, Zografos GC, Psaltopoulou T, Gnant M, Dimopoulos MA, Bartsch R. Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series. Br J Cancer. 2013;108(11):2259\u201363.", "journal-title": "Br J Cancer"}, {"issue": "1", "key": "12_CR5", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/s10549-013-2675-y", "volume": "141", "author": "L Lauro Di", "year": "2013", "unstructured": "Di Lauro L, Vici P, Del Medico P, Laudadio L, Tomao S, Giannarelli D, Pizzuti L, Sergi D, Barba M, Maugeri-Sacc\u00e0 M. Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer. Breast Cancer Res Treat. 2013;141(1):119\u201323.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "2", "key": "12_CR6", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1007/s10549-012-2355-3", "volume": "137", "author": "H Eggemann", "year": "2013", "unstructured": "Eggemann H, Ignatov A, Smith BJ, Altmann U, von Minckwitz G, R\u00f6hl FW, Jahn M, Costa SD. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast Cancer Res Treat. 2013;137(2):465\u201370.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "5", "key": "12_CR7", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1016/j.clbc.2013.04.003", "volume": "13", "author": "DK Patten", "year": "2013", "unstructured": "Patten DK, Sharifi LK, Fazel M. New approaches in the management of male breast cancer. Clin Breast Cancer. 2013;13(5):309\u201314.", "journal-title": "Clin Breast Cancer"}, {"issue": "1\u20135", "key": "12_CR8", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1016/j.jsbmb.2007.05.027", "volume": "106", "author": "SE Bulun", "year": "2007", "unstructured": "Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakim A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z. Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol. 2007;106(1\u20135):81\u201396.", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "24", "key": "12_CR9", "doi-asserted-by": "crossref", "first-page": "11287", "DOI": "10.1158/0008-5472.CAN-05-2737", "volume": "65", "author": "OK Weinberg", "year": "2005", "unstructured": "Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65(24):11287\u201391.", "journal-title": "Cancer Res"}, {"key": "12_CR10", "first-page": "593", "volume": "19", "author": "H Sasano", "year": "1998", "unstructured": "Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev. 1998;19:593\u2013607.", "journal-title": "Endocr Rev"}, {"issue": "6", "key": "12_CR11", "doi-asserted-by": "crossref", "first-page": "4007", "DOI": "10.1007/s13277-013-0991-9", "volume": "34", "author": "K Jarzabek", "year": "2013", "unstructured": "Jarzabek K, Koda M, Walentowicz-Sadlecka M, Grabiec M, Laudanski P, Wolczynski S. Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology. Tumour Biol. 2013;34(6):4007\u201316.", "journal-title": "Tumour Biol"}, {"key": "12_CR12", "first-page": "27", "volume": "31", "author": "WR Miller", "year": "2006", "unstructured": "Miller WR. Aromatase inhibitors and breast cancer. Minerva Endocrinol. 2006;31:27\u201346.", "journal-title": "Minerva Endocrinol"}, {"key": "12_CR13", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1210/jcem-57-6-1125", "volume": "57", "author": "N Tilson-Mallett", "year": "1983", "unstructured": "Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ. Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metabol. 1983;57:1125\u20138.", "journal-title": "J Clin Endocrinol Metabol"}, {"issue": "8", "key": "12_CR14", "doi-asserted-by": "crossref", "first-page": "495", "DOI": "10.1007/BF01187162", "volume": "122", "author": "LM Berstein", "year": "1996", "unstructured": "Berstein LM, Larionov AA, Kyshtoobaeva ASh, Pozharisski KM, Semiglazov VF, Ivanova OA. Aromatase in breast cancer tissue\u2013localization and relationship with reproductive status of patients. J Cancer Res Clin Oncol. 1996;122(8):495\u20138.", "journal-title": "J Cancer Res Clin Oncol"}, {"key": "12_CR15", "unstructured": "Ma XX, Zhang SL, Gao S, Lu JM, Dong F. Expressions of aromatase protein and sex hormone receptor in endometrial lesions. Zhonghua Fu Chan Ke Za Zhi. 2006; 41(6):395\u2013398. ([Article in Chinese] PMID: 16831363 [PubMed - indexed for MEDLINE])."}, {"issue": "1", "key": "12_CR16", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.2478/v10039-012-0055-1", "volume": "58", "author": "P Knapp", "year": "2013", "unstructured": "Knapp P, Chabowski A, B\u0142achnio-Zabielska A, Walentowicz-Sad\u0142ecka M, Grabiec M, Knapp PA. Expression of estrogen receptors (\u03b1, \u03b2), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus. Adv Med Sci. 2013;58(1):96\u2013103.", "journal-title": "Adv Med Sci"}, {"issue": "2", "key": "12_CR17", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1054/brst.2000.0209", "volume": "10", "author": "PC Jong de", "year": "2001", "unstructured": "de Jong PC, Blankenstein MA, van de Ven J, Nortier JW, Blijham GH, Thijssen JH. Importance of local aromatase activity in hormone-dependent breast cancer: a review. Breast. 2001;10(2):91\u20139.", "journal-title": "Breast"}, {"issue": "3", "key": "12_CR18", "doi-asserted-by": "crossref", "first-page": "902", "DOI": "10.3892/etm.2012.878", "volume": "5", "author": "C Ghimenti", "year": "2013", "unstructured": "Ghimenti C, Mello-Grand M, Grosso E, Scatolini M, Regolo L, Zambelli A, Chiorino G. Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy. Exp Ther Med. 2013;5(3):902\u20136.", "journal-title": "Exp Ther Med"}, {"key": "12_CR19", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1007/s10549-006-9198-8", "volume": "99", "author": "M Salhab", "year": "2006", "unstructured": "Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Res Treat. 2006;99:155\u201362.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "1", "key": "12_CR20", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1158/0008-5472.CAN-09-3224", "volume": "70", "author": "L Wang", "year": "2010", "unstructured": "Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, Fridley BL, Jenkins GD, Batzler A, Suman VJ, Ravi S, Dixon JM, Miller WR, Wieben ED, Buzdar A, Weinshilboum RM, Ingle JN. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res. 2010;70(1):319\u201328.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "12_CR21", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1186/bcr2931", "volume": "14", "author": "WR Miller", "year": "2012", "unstructured": "Miller WR, Larionov AA. Understanding the mechanisms of aromatase inhibitor resistance. Breast Cancer Res. 2012;14(1):201.", "journal-title": "Breast Cancer Res"}, {"issue": "6", "key": "12_CR22", "first-page": "1458", "volume": "76", "author": "SE Bulun", "year": "1993", "unstructured": "Bulun SE, Mahendroo MS, Simpson ER. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J Clin Endocrinol Metab. 1993;76(6):1458\u201363.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "6", "key": "12_CR23", "first-page": "1831", "volume": "79", "author": "SE Bulun", "year": "1994", "unstructured": "Bulun SE, Economos K, Miller D, Simpson ER. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab. 1994;79(6):1831\u20134.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "1\u20135", "key": "12_CR24", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1016/j.jsbmb.2005.04.008", "volume": "95", "author": "L Berstein", "year": "2005", "unstructured": "Berstein L, Kovalevskij A, Zimarina T, Maximov S, Gershfeld E, Vasilyev D, Baisheva S, Baymakhasheva A, Thijssen JH. Aromatase and comparative response to its inhibitors in two types of endometrial cancer. J Steroid Biochem Mol Biol. 2005;95(1\u20135):71\u20134.", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "12_CR25", "unstructured": "Bershte\u012dn LM, Danilova MA, Kovalevski\u012d AIu, Gershfel\u2019d ED, Poroshina TE, Tsyrlina TE, Meshkova IE, Turkevich EA, Maksimov SIa. Criteria for evaluating the effectiveness of aromatase inhibitors in the neoadjuvant treatment of patients with endometrial carcinoma. Vopr Onkol. 2009;55(3):314\u2013318. ([Article in Russian] PMID: 19670731 [PubMed\u2014indexed for MEDLINE])."}, {"issue": "2", "key": "12_CR26", "doi-asserted-by": "crossref", "first-page": "E330", "DOI": "10.1210/jc.2010-2050", "volume": "96", "author": "E Audet-Walsh", "year": "2011", "unstructured": "Audet-Walsh E, L\u00e9pine J, Gr\u00e9goire J, Plante M, Caron P, T\u00eatu B, Ayotte P, Brisson J, Villeneuve L, B\u00e9langer A, Guillemette C. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab. 2011;96(2):E330\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "12_CR27", "doi-asserted-by": "crossref", "first-page": "166", "DOI": "10.1007/978-0-387-78818-0_11", "volume": "630", "author": "C Gr\u00fcndker", "year": "2008", "unstructured": "Gr\u00fcndker C, G\u00fcnthert AR, Emons G. Hormonal heterogeneity of endometrial cancer. Adv Exp Med Biol. 2008;630:166\u201388.", "journal-title": "Adv Exp Med Biol"}, {"issue": "2", "key": "12_CR28", "first-page": "115", "volume": "52", "author": "L Berstein", "year": "2005", "unstructured": "Berstein L, Zimarina T, Kovalevskij A, Maximov S, Volkov O, Thijssen JH. CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease. Neoplasma. 2005;52(2):115\u20138.", "journal-title": "Neoplasma"}, {"issue": "4", "key": "12_CR29", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1016/j.maturitas.2006.04.017", "volume": "54", "author": "L Berstein", "year": "2006", "unstructured": "Berstein L, Zimarina T, Imyanitov E, Kovalevskij A, Maximov S, Pujol P, Thijssen J. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes. Maturitas. 2006;54(4):352\u20135.", "journal-title": "Maturitas"}, {"key": "12_CR30", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1016/0090-8258(83)90111-7", "volume": "15", "author": "JV Bokhman", "year": "1983", "unstructured": "Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15:10\u20137.", "journal-title": "Gynecol Oncol"}, {"issue": "3", "key": "12_CR31", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1038/modpathol.3880051", "volume": "13", "author": "ME Sherman", "year": "2000", "unstructured": "Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol. 2000;13(3):295\u2013308.", "journal-title": "Mod Pathol"}, {"key": "12_CR32", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1136/ijgc-00009577-200505000-00019", "volume": "15", "author": "VH Jongen", "year": "2005", "unstructured": "Jongen VH, Thijssen JH, Hollema H, Donker GH, Santema JG, Van der Zee AG, Heineman MJ. Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer? Int J Gynecol Cancer. 2005;15:529\u201336.", "journal-title": "Int J Gynecol Cancer"}, {"key": "12_CR33", "first-page": "491", "volume": "146", "author": "K Watanabe", "year": "1995", "unstructured": "Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A. Aromatase in human endometrial carcinoma and hyperplasia, immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol. 1995;146:491\u2013500.", "journal-title": "Am J Pathol"}, {"issue": "2", "key": "12_CR34", "doi-asserted-by": "crossref", "first-page": "469", "DOI": "10.1016/j.fertnstert.2005.12.057", "volume": "86", "author": "N Pathirage", "year": "2006", "unstructured": "Pathirage N, Di Nezza LA, Salmonsen LA, Jobling T, Simpson ER, Clyne CD. Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer. Fertil Steril. 2006;86(2):469\u201372.", "journal-title": "Fertil Steril"}, {"key": "12_CR35", "first-page": "2263", "volume": "86", "author": "L Masi", "year": "2001", "unstructured": "Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, Silvestri S, Gonnelli S, Brandi ML. Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlatoion with bone mass and fracture risk. J Clin Endocrin Metab. 2001;86:2263\u20139.", "journal-title": "J Clin Endocrin Metab"}, {"key": "12_CR36", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/S0304-3835(02)00019-8", "volume": "180", "author": "LM Berstein", "year": "2002", "unstructured": "Berstein LM, Imyanitov EN, Gamajunova VB, Kovalevskij AJ, Kuligina ESh, Belogubova EV, Buslov KG, Karpova MB, Togo AV, Volkov ON, Kovalenko IG. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? Cancer Lett. 2002;180:47\u201353.", "journal-title": "Cancer Lett"}, {"key": "12_CR37", "unstructured": "Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ; Australian National Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, H\u00e5kansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013; 31(20): 2607\u20132618.", "DOI": "10.1200/JCO.2012.48.2596", "doi-asserted-by": "crossref"}, {"key": "12_CR38", "unstructured": "Martin-Hirsch PP, Bryant A, Keep SL, Kitchener HC, Lilford R. Adjuvant progestagens for endometrial cancer. Cochrane Database Syst Rev. 2011; 6:CD001040.", "DOI": "10.1002/14651858.CD001040.pub2", "doi-asserted-by": "crossref"}, {"key": "12_CR39", "doi-asserted-by": "publisher", "first-page": "429", "DOI": "10.2147/IJWH.S40942", "volume": "6", "author": "MJ Carlson", "year": "2014", "unstructured": "Carlson MJ, Thiel KW, Leslie KK. Past, present, and future of hormonal therapy in recurrent endometrial cancer. Int J Womens Health. 2014;6:429\u201335. doi:\n                  10.2147/IJWH.S40942\n                  \n                .", "journal-title": "Int J Womens Health"}, {"issue": "7", "key": "12_CR40", "doi-asserted-by": "crossref", "first-page": "664", "DOI": "10.1016/S1701-2163(16)35320-8", "volume": "34", "author": "AD Altman", "year": "2012", "unstructured": "Altman AD, Thompson J, Nelson G, Chu P, Nation J, Ghatage P. Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study. J Obstet Gynaecol Can. 2012;34(7):664\u201372.", "journal-title": "J Obstet Gynaecol Can"}, {"issue": "2", "key": "12_CR41", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1093/humrep/dei322", "volume": "21", "author": "S Duffy", "year": "2006", "unstructured": "Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Coibion M, Bianco AR. The ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2\u00a0years of treatment. Hum Reprod. 2006;21(2):545\u201353.", "journal-title": "Hum Reprod"}, {"issue": "6", "key": "12_CR42", "doi-asserted-by": "crossref", "first-page": "596", "DOI": "10.3109/01443615.2010.492433", "volume": "30", "author": "S Duffy", "year": "2010", "unstructured": "Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Clack G, Bianco AR. ATAC Trialists\u2019 Group. The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol. J Obstet Gynaecol. 2010;30(6):596\u2013604.", "journal-title": "J Obstet Gynaecol"}, {"issue": "2", "key": "12_CR43", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/0090-8258(85)90135-0", "volume": "20", "author": "JV Bokhman", "year": "1985", "unstructured": "Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol. 1985;20(2):139\u201355.", "journal-title": "Gynecol Oncol"}, {"issue": "2", "key": "12_CR44", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1002/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2", "volume": "79", "author": "YB Kim", "year": "1997", "unstructured": "Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer. 1997;79(2):320\u20137.", "journal-title": "Cancer"}, {"issue": "Suppl 6", "key": "12_CR45", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1080/gye.15.s6.29.36", "volume": "15", "author": "AE Schindler", "year": "2001", "unstructured": "Schindler AE. Progestins and endometrial cancer. Gynecol Endocrinol. 2001;15(Suppl 6):29\u201336.", "journal-title": "Gynecol Endocrinol"}, {"issue": "2", "key": "12_CR46", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0301-2115(02)00147-1", "volume": "105", "author": "L Berstein", "year": "2002", "unstructured": "Berstein L, Maximov S, Gershfeld E, Meshkova I, Gamajunova V, Tsyrlina E, Larionov A, Kovalevskij A, Vasilyev D. Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects. Eur J Obstet Gynecol Reprod Biol. 2002;105(2):161\u20135.", "journal-title": "Eur J Obstet Gynecol Reprod Biol"}, {"issue": "3", "key": "12_CR47", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1007/s10549-014-2835-8", "volume": "144", "author": "R Carpenter", "year": "2014", "unstructured": "Carpenter R, Doughty JC, Cordiner C, Moss N, Gandhi A, Wilson C, Andrews C, Ellis G, Gui G, Skene AI. Optimum duration of neoadjuvant letrozole to permit breast conserving surgery. Breast Cancer Res Treat. 2014;144(3):569\u201376.", "journal-title": "Breast Cancer Res Treat"}, {"issue": "3", "key": "12_CR48", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1016/j.ygyno.2013.09.023", "volume": "131", "author": "A Thangavelu", "year": "2013", "unstructured": "Thangavelu A, Hewitt MJ, Quinton ND, Duffy SR. Neoadjuvant treatment of endometrial cancer using anastrozole: a randomised pilot study. Gynecol Oncol. 2013;131(3):613\u20138.", "journal-title": "Gynecol Oncol"}, {"key": "12_CR49", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1006/gyno.2000.5865", "volume": "78", "author": "PG Rose", "year": "2000", "unstructured": "Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2000;78:212\u20136.", "journal-title": "Gynecol Oncol"}, {"key": "12_CR50", "first-page": "650", "volume": "14", "author": "BB Ma", "year": "2004", "unstructured": "Ma BB, Oza A, Eisenhauer E, Stanimir G, Carey M, Chapman W, Latta E, Sidhu K, Powers J, Walsh W, Fyles A. The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers\u2013a study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Cancer. 2004;14:650\u20138.", "journal-title": "Int J Gynecol Cancer"}, {"key": "12_CR51", "unstructured": "Nordstrom B, Salmi T, Mirza M, Abeler V, Kristensen G. Exemestane in advanced and recurrent endometrial carcinoma. A phase II study. J Clin Oncol. 2006; 24:5042 (ASCO 2006, Supplement, Abstr)."}, {"key": "12_CR52", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1186/1471-2407-14-68", "volume": "14", "author": "K Lindemann", "year": "2014", "unstructured": "Lindemann K, Malander S, Christensen RD, Mirza MR, Kristensen GB, Aavall-Lundqvist E, Vergote I, Rosenberg P, Boman K, Nordstr\u00f8m B. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO). BMC Cancer. 2014;14:68.", "journal-title": "BMC Cancer"}, {"issue": "5", "key": "12_CR53", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1016/j.jcma.2014.02.007", "volume": "77", "author": "WL Lee", "year": "2014", "unstructured": "Lee WL, Yen MS, Chao KC, Yuan CC, Ng HT, Chao HT, Lee FK, Wang PH. Hormone therapy for patients with advanced or recurrent endometrial cancer. J Chin Med Assoc. 2014;77(5):221\u20136.", "journal-title": "J Chin Med Assoc"}, {"issue": "8", "key": "12_CR54", "doi-asserted-by": "crossref", "first-page": "1770", "DOI": "10.1093/annonc/mdq700", "volume": "22", "author": "H Anderson", "year": "2011", "unstructured": "Anderson H, Hills M, Zabaglo L, A\u2019hern R, Leary AF, Haynes BP, Smith IE, Dowsett M. Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer. Ann Oncol. 2011;22(8):1770\u20136.", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "12_CR55", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1016/j.ygyno.2014.04.060", "volume": "134", "author": "C Gao", "year": "2014", "unstructured": "Gao C, Wang Y, Tian W, Zhu Y, Xue F. The therapeutic significance of aromatase inhibitors in endometrial carcinoma. Gynecol Oncol. 2014;134(1):190\u20135. doi:\n                  10.1016/j.ygyno.2014.04.060\n                  \n                .", "journal-title": "Gynecol Oncol"}, {"key": "12_CR56", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1007/978-0-387-78818-0_8", "volume": "630", "author": "SE Bulun", "year": "2008", "unstructured": "Bulun SE, Simpson ER. Aromatase expression in women\u2019s cancers. Adv Exp Med Biol. 2008;630:112\u201332.", "journal-title": "Adv Exp Med Biol"}, {"issue": "2", "key": "12_CR57", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/j.mce.2010.11.023", "volume": "340", "author": "K Ito", "year": "2011", "unstructured": "Ito K, Utsunomiya H, Niikura H, Yaegashi N, Sasano H. Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer. Mol Cell Endocrinol. 2011;340(2):161\u20137.", "journal-title": "Mol Cell Endocrinol"}, {"issue": "6", "key": "12_CR58", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1016/j.steroids.2013.01.008", "volume": "78", "author": "F Simpkins", "year": "2013", "unstructured": "Simpkins F, Garcia-Soto A, Slingerland J. New insights on the role of hormonal therapy in ovarian cancer. Steroids. 2013;78(6):530\u20137.", "journal-title": "Steroids"}, {"issue": "1", "key": "12_CR59", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1097/IGC.0b013e3182788466", "volume": "23", "author": "D Zhao", "year": "2013", "unstructured": "Zhao D, Zhang F, Zhang W, He J, Zhao Y, Sun J. Prognostic role of hormone receptors in ovarian cancer: a systematic review and meta-analysis. Int J Gynecol Cancer. 2013;23(1):25\u201333.", "journal-title": "Int J Gynecol Cancer"}, {"issue": "1", "key": "12_CR60", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/j.jsbmb.2004.10.021", "volume": "93", "author": "S Cunat", "year": "2005", "unstructured": "Cunat S, Rabenoelina F, Daur\u00e8s JP, Katsaros D, Sasano H, Miller WR, Maudelonde T, Pujol P. Aromatase expression in ovarian epithelial cancers. J Steroid Biochem Mol Biol. 2005;93(1):15\u201324.", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "6", "key": "12_CR61", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.12998/wjcc.v1.i6.187", "volume": "1", "author": "Y Yokoyama", "year": "2013", "unstructured": "Yokoyama Y, Mizunuma H. Recurrent epithelial ovarian cancer and hormone therapy. World J Clin Cases. 2013;1(6):187\u201390.", "journal-title": "World J Clin Cases"}, {"issue": "7", "key": "12_CR62", "first-page": "1328", "volume": "21", "author": "KM Sjoquist", "year": "2011", "unstructured": "Sjoquist KM, Martyn J, Edmondson RJ, Friedlander ML. The role of hormonal therapy in gynecological cancers-current status and future directions. Int J Gynecol Cancer. 2011;21(7):1328\u201333.", "journal-title": "Int J Gynecol Cancer"}, {"issue": "6", "key": "12_CR63", "doi-asserted-by": "crossref", "first-page": "R255", "DOI": "10.1530/ERC-12-0175", "volume": "19", "author": "F Modugno", "year": "2012", "unstructured": "Modugno F, Laskey R, Smith AL, Andersen CL, Haluska P, Oesterreich S. Hormone response in ovarian cancer: time to reconsider as a clinical target? Endocr Relat Cancer. 2012;19(6):R255\u201379.", "journal-title": "Endocr Relat Cancer"}, {"issue": "1", "key": "12_CR64", "doi-asserted-by": "publisher", "first-page": "196", "DOI": "10.1016/j.ygyno.2014.03.573", "volume": "134", "author": "HS Meurs van", "year": "2014", "unstructured": "van Meurs HS, van Lonkhuijzen LR, Limpens J, van der Velden J, Buist MR. Hormone therapy in ovarian granulosa cell tumors: a systematic review. Gynecol Oncol. 2014;134(1):196\u2013205. doi:\n                  10.1016/j.ygyno.2014.03.573\n                  \n                .", "journal-title": "Gynecol Oncol"}, {"issue": "10", "key": "12_CR65", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1007/s10815-011-9573-1", "volume": "28", "author": "Q Meng", "year": "2011", "unstructured": "Meng Q, Sun W, Jiang J, Fletcher NM, Diamond MP, Saed GM. Identification of common mechanisms between endometriosis and ovarian cancer. J Assist Reprod Genet. 2011;28(10):917\u201323.", "journal-title": "J Assist Reprod Genet"}, {"issue": "2", "key": "12_CR66", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1038/nrc726", "volume": "2", "author": "SA Narod", "year": "2002", "unstructured": "Narod SA. Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002;2(2):113\u201323.", "journal-title": "Nat Rev Cancer"}, {"key": "12_CR67", "doi-asserted-by": "crossref", "first-page": "148", "DOI": "10.1186/1471-2407-9-148", "volume": "9", "author": "AL Chand", "year": "2009", "unstructured": "Chand AL, Simpson ER, Clyne CD. Aromatase expression is increased in BRCA1 mutation carriers. BMC Cancer. 2009;9:148.", "journal-title": "BMC Cancer"}, {"issue": "3", "key": "12_CR68", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1007/s12253-008-9137-6", "volume": "15", "author": "LM Berstein", "year": "2009", "unstructured": "Berstein LM, Pozharisski KM, Imyanitov EN, Maximova NA, Kovalevskij AY. Aromatase, CYP1B1 and fatty acid synthase expression in breast tumors of BRCA1 mutation carriers. Pathol Oncol Res. 2009;15(3):407\u20139.", "journal-title": "Pathol Oncol Res"}, {"key": "12_CR69", "unstructured": "http://seer.cancer.gov/statfacts/html/lungb.html\n                  \n                . Approached 21 July 2014."}, {"key": "12_CR70", "first-page": "417", "volume": "92", "author": "J Marmorston", "year": "1965", "unstructured": "Marmorston J, Gierson HW, Myers SM, Stern E. Urinary excretion of estrone, estradiol, and estriol by patients with lung cancer and emphysema. Am Rev Respir Dis. 1965;92:417\u201327.", "journal-title": "Am Rev Respir Dis"}, {"key": "12_CR71", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1093/jnci/86.11.869", "volume": "86", "author": "E Taioli", "year": "1994", "unstructured": "Taioli E, Wynder EL. Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 1994;86:869\u201370.", "journal-title": "J Natl Cancer Inst"}, {"key": "12_CR72", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1200/JCO.2005.02.9827", "volume": "24", "author": "AK Ganti", "year": "2006", "unstructured": "Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2006;24:59\u201363.", "journal-title": "J Clin Oncol"}, {"key": "12_CR73", "doi-asserted-by": "crossref", "first-page": "6450", "DOI": "10.1158/0008-5472.CAN-04-3087", "volume": "65", "author": "H Ishibashi", "year": "2005", "unstructured": "Ishibashi H, Suzuki T, Suzuki S, Niikawa H, Lu L, Miki Y, Moriya T, Hayashi S, Handa M, Kondo T, Sasano H. Progesterone receptor in non-small cell lung cancer\u2013a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 2005;65:6450\u20138.", "journal-title": "Cancer Res"}, {"issue": "20", "key": "12_CR74", "doi-asserted-by": "crossref", "first-page": "7280", "DOI": "10.1158/1078-0432.CCR-05-0498", "volume": "11", "author": "AG Schwartz", "year": "2005", "unstructured": "Schwartz AG, Prysak GM, Murphy V, Lonardo F, Pass H, Schwartz J, Brooks S. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11(20):7280\u20137.", "journal-title": "Clin Cancer Res"}, {"issue": "15\u201316", "key": "12_CR75", "doi-asserted-by": "crossref", "first-page": "800", "DOI": "10.1016/j.lfs.2012.08.029", "volume": "91", "author": "MK Verma", "year": "2012", "unstructured": "Verma MK, Miki Y, Abe K, Nagasaki S, Niikawa H, Suzuki S, Kondo T, Sasano H. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome. Life Sci. 2012;91(15\u201316):800\u20138.", "journal-title": "Life Sci"}, {"issue": "21", "key": "12_CR76", "doi-asserted-by": "crossref", "first-page": "10484", "DOI": "10.1158/0008-5472.CAN-07-2607", "volume": "67", "author": "V Mah", "year": "2007", "unstructured": "Mah V, Seligson DB, Li A, M\u00e1rquez DC, Wistuba II, Elshimali Y, Fishbein MC, Chia D, Pietras RJ, Goodglick L. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res. 2007;67(21):10484\u201390.", "journal-title": "Cancer Res"}, {"issue": "4", "key": "12_CR77", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.2217/lmt.12.44", "volume": "1", "author": "N Kazmi", "year": "2012", "unstructured": "Kazmi N, M\u00e1rquez-Garb\u00e1n DC, Aivazyan L, Hamilton N, Garon EB, Goodglick L, Pietras RJ. The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manage. 2012;1(4):259\u201372.", "journal-title": "Lung Cancer Manage"}, {"issue": "24", "key": "12_CR78", "doi-asserted-by": "crossref", "first-page": "11287", "DOI": "10.1158/0008-5472.CAN-05-2737", "volume": "65", "author": "OK Weinberg", "year": "2005", "unstructured": "Weinberg OK, Marquez-Garban DC, Fishbein MC, Goodglick L, Garban HJ, Dubinett SM, Pietras RJ. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65(24):11287\u201391.", "journal-title": "Cancer Res"}, {"issue": "1", "key": "12_CR79", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1053/j.seminoncol.2013.12.009", "volume": "41", "author": "JM Siegfried", "year": "2014", "unstructured": "Siegfried JM, Stabile LP. Estrogenic steroid hormones in lung cancer. Semin Oncol. 2014;41(1):5\u201316.", "journal-title": "Semin Oncol"}, {"issue": "5", "key": "12_CR80", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1016/j.biopha.2012.02.004", "volume": "66", "author": "R Xu", "year": "2012", "unstructured": "Xu R, Shen H, Guo R, Sun J, Gao W, Shu Y. Combine therapy of gefitinib and fulvestrant enhances antitumor effects on NSCLC cell lines with acquired resistance to gefitinib. Biomed Pharmacother. 2012;66(5):384\u20139.", "journal-title": "Biomed Pharmacother"}, {"issue": "3", "key": "12_CR81", "first-page": "855", "volume": "31", "author": "T Onitsuka", "year": "2011", "unstructured": "Onitsuka T, Uramoto H, Tanaka F. Lack of direct association between EGFR mutations and ER beta expression in lung cancer. Anticancer Res. 2011;31(3):855\u201360.", "journal-title": "Anticancer Res"}, {"issue": "5", "key": "12_CR82", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1016/S1470-2045(06)70693-3", "volume": "7", "author": "S Dubey", "year": "2006", "unstructured": "Dubey S, Siegfried JM, Traynor AM. Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond. Lancet Oncol. 2006;7(5):416\u201324.", "journal-title": "Lancet Oncol"}, {"issue": "6", "key": "12_CR83", "doi-asserted-by": "crossref", "first-page": "1006", "DOI": "10.1097/IGC.0b013e31825b7de8", "volume": "22", "author": "AD Altman", "year": "2012", "unstructured": "Altman AD, Nelson GS, Chu P, Nation J, Ghatage P. Uterine sarcoma and aromatase inhibitors: Tom Baker Cancer Centre experience and review of the literature. Int J Gynecol Cancer. 2012;22(6):1006\u201312.", "journal-title": "Int J Gynecol Cancer"}, {"issue": "5", "key": "12_CR84", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.1002/cncr.28476", "volume": "120", "author": "S George", "year": "2014", "unstructured": "George S, Feng Y, Manola J, Nucci MR, Butrynski JE, Morgan JA, Ramaiya N, Quek R, Penson RT, Wagner AJ, Harmon D, Demetri GD, Krasner C. Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. Cancer. 2014;120(5):738\u201343.", "journal-title": "Cancer"}, {"issue": "3", "key": "12_CR85", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1586/eem.11.20", "volume": "6", "author": "JL Nelles", "year": "2011", "unstructured": "Nelles JL, Hu WY, Prins GS. Estrogen action and prostate cancer. Expert Rev Endocrinol Metab. 2011;6(3):437\u201351.", "journal-title": "Expert Rev Endocrinol Metab"}, {"issue": "4\u20135", "key": "12_CR86", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1016/j.jsbmb.2009.10.015", "volume": "118", "author": "SJ Ellem", "year": "2010", "unstructured": "Ellem SJ, Risbridger GP. Aromatase and regulating the estrogen:androgen ratio in the prostate gland. J Steroid Biochem Mol Biol. 2010;118(4\u20135):246\u201351.", "journal-title": "J Steroid Biochem Mol Biol"}, {"issue": "1\u20132", "key": "12_CR87", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/j.mce.2011.08.032", "volume": "354", "author": "WY Hu", "year": "2012", "unstructured": "Hu WY, Shi GB, Hu DP, Nelles JL, Prins GS. Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk. Mol Cell Endocrinol. 2012;354(1\u20132):63\u201373.", "journal-title": "Mol Cell Endocrinol"}, {"issue": "6", "key": "12_CR88", "doi-asserted-by": "crossref", "first-page": "1175", "DOI": "10.1210/me.2009-0470", "volume": "24", "author": "L Miao", "year": "2010", "unstructured": "Miao L, Shi J, Wang CY, Zhu Y, Du X, Jiao H, Mo Z, Klocker H, Lee C, Zhang J. Estrogen receptor-related receptor alpha mediates up-regulation of aromatase expression by prostaglandin E2 in prostate stromal cells. Mol Endocrinol. 2010;24(6):1175\u201386.", "journal-title": "Mol Endocrinol"}, {"key": "12_CR89", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.4103/1477-3163.90678", "volume": "10", "author": "MC Bosland", "year": "2011", "unstructured": "Bosland MC, Mahmoud AM. Hormones and prostate carcinogenesis: Androgens and estrogens. J Carcinog. 2011;10:33.", "journal-title": "J Carcinog"}, {"issue": "12", "key": "12_CR90", "doi-asserted-by": "crossref", "first-page": "1773", "DOI": "10.1586/14737140.7.12.1773", "volume": "7", "author": "PR Sieber", "year": "2007", "unstructured": "Sieber PR. Treatment of bicalutamide-induced breast events. Expert Rev Anticancer Ther. 2007;7(12):1773\u20139.", "journal-title": "Expert Rev Anticancer Ther"}, {"issue": "9", "key": "12_CR91", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1097/00001813-200410000-00004", "volume": "15", "author": "WH Kruit", "year": "2004", "unstructured": "Kruit WH, Stoter G, Klijn JG. Effect of combination therapy with aminoglutethimide and hydrocortisone on prostate-specific antigen response in metastatic prostate cancer refractory to standard endocrine therapy. Anticancer Drugs. 2004;15(9):843\u20137.", "journal-title": "Anticancer Drugs"}, {"key": "12_CR92", "doi-asserted-by": "crossref", "first-page": "1811", "DOI": "10.1016/0277-5379(88)90090-9", "volume": "24", "author": "RJ Santen", "year": "1988", "unstructured": "Santen RJ, Santner SJ, Harvey HA, Lipton A, Simmonds M, Feil PD, Manders E, Davis TS. Marked heterogeneity of aromatase activity in human malignant melanoma tissue. Eur J Cancer Clin Oncol. 1988;24:1811\u20136.", "journal-title": "Eur J Cancer Clin Oncol"}, {"issue": "3", "key": "12_CR93", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1097/00000421-199206000-00016", "volume": "15", "author": "S Block", "year": "1992", "unstructured": "Block S, Bonneterre J, Adenis A, Pion JM, Demaille A. Aminoglutethimide in malignant melanoma. A phase II study. Am J Clin Oncol. 1992;15(3):260\u20131.", "journal-title": "Am J Clin Oncol"}, {"issue": "3", "key": "12_CR94", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1016/j.ygyno.2009.05.041", "volume": "114", "author": "P Veerapaneni", "year": "2009", "unstructured": "Veerapaneni P, Kirma N, Nair HB, Hammes LS, Hall KL, Tekmal RR. Elevated aromatase expression correlates with cervical carcinoma progression. Gynecol Oncol. 2009;114(3):496\u2013500.", "journal-title": "Gynecol Oncol"}, {"issue": "10", "key": "12_CR95", "first-page": "3702", "volume": "83", "author": "L Dalla Valle", "year": "1998", "unstructured": "Dalla Valle L, Ramina A, Vianello S, Fassina A, Belvedere P, Colombo L. Potential for estrogen synthesis and action in human normal and neoplastic thyroid tissues. J Clin Endocrinol Metab. 1998;83(10):3702\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "6", "key": "12_CR96", "doi-asserted-by": "crossref", "first-page": "737", "DOI": "10.1007/s00384-012-1628-y", "volume": "28", "author": "PA Foster", "year": "2013", "unstructured": "Foster PA. Oestrogen and colorectal cancer: mechanisms and controversies. Int J Colorectal Dis. 2013;28(6):737\u201349.", "journal-title": "Int J Colorectal Dis"}, {"issue": "3", "key": "12_CR97", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1002/cam4.85", "volume": "2", "author": "S Hata", "year": "2013", "unstructured": "Hata S, Miki Y, Saito R, Ishida K, Watanabe M, Sasano H. Aromatase in human liver and its diseases. Cancer Med. 2013;2(3):305\u201315.", "journal-title": "Cancer Med"}, {"issue": "15", "key": "12_CR98", "doi-asserted-by": "crossref", "first-page": "3383", "DOI": "10.1002/cncr.25939", "volume": "117", "author": "WP Koh", "year": "2011", "unstructured": "Koh WP, Yuan JM, Wang R, Govindarajan S, Oppenheimer R, Zhang ZQ, Yu MC, Ingles SA. Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma. Cancer. 2011;117(15):3383\u201392.", "journal-title": "Cancer"}, {"issue": "11", "key": "12_CR99", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.3109/09513590.2011.569606", "volume": "27", "author": "E Przybylik-Mazurek", "year": "2011", "unstructured": "Przybylik-Mazurek E, Hubalewska-Dydejczyk A, Fedorowicz A, Pach D. Factors connected with the female sex seem to play an important role in differentiated thyroid cancer. Gynecol Endocrinol. 2011;27(11):961\u20135.", "journal-title": "Gynecol Endocrinol"}, {"key": "12_CR100", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1196/annals.1434.007", "volume": "1127", "author": "S Ozkan", "year": "2008", "unstructured": "Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann NY Acad Sci. 2008;1127:92\u2013100.", "journal-title": "Ann NY Acad Sci"}, {"issue": "2", "key": "12_CR101", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1210/jc.2008-1180", "volume": "94", "author": "E Attar", "year": "2009", "unstructured": "Attar E, Tokunaga H, Imir G, Yilmaz MB, Redwine D, Putman M, Gurates B, Attar R, Yaegashi N, Hales DB, Bulun SE. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94(2):623\u201331.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "7", "key": "12_CR102", "doi-asserted-by": "crossref", "first-page": "E1191", "DOI": "10.1210/jc.2013-2525", "volume": "99", "author": "I Suganuma", "year": "2014", "unstructured": "Suganuma I, Mori T, Ito F, Tanaka Y, Sasaki A, Matsuo S, Kusuki I, Kitawaki J. Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha enhances local estrogen biosynthesis by stimulating aromatase activity in endometriosis. J Clin Endocrinol Metab. 2014;99(7):E1191\u20138.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "12_CR103", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1186/1477-7827-9-89", "volume": "9", "author": "S Ferrero", "year": "2011", "unstructured": "Ferrero S, Gillott DJ, Venturini PL, Remorgida V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol. 2011;9:89.", "journal-title": "Reprod Biol Endocrinol"}, {"issue": "6", "key": "12_CR104", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1016/j.fertnstert.2012.08.053", "volume": "98", "author": "ME Pavone", "year": "2012", "unstructured": "Pavone ME, Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98(6):1370\u20139.", "journal-title": "Fertil Steril"}, {"key": "12_CR105", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1186/1477-7827-9-90", "volume": "9", "author": "NP Polyzos", "year": "2011", "unstructured": "Polyzos NP, Fatemi HM, Zavos A, Grimbizis G, Kyrou D, Velasco JG, Devroey P, Tarlatzis B, Papanikolaou EG. Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 2011;9:90.", "journal-title": "Reprod Biol Endocrinol"}, {"key": "12_CR106", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1517/13543784.2011.581226", "volume": "20", "author": "S Colette", "year": "2011", "unstructured": "Colette S, Donnez J. Are aromatase inhibitors effective in endometriosis treatment? Expert Opin Investig Drugs. 2011;20:917\u201331.", "journal-title": "Expert Opin Investig Drugs"}, {"issue": "2", "key": "12_CR107", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.5653/cerm.2013.40.2.55", "volume": "40", "author": "SH Kim", "year": "2013", "unstructured": "Kim SH, Chae HD, Kim CH, Kang BM. Update on the treatment of endometriosis. Clin Exp Reprod Med. 2013;40(2):55\u20139.", "journal-title": "Clin Exp Reprod Med"}, {"key": "12_CR108", "unstructured": "George K, Kamath MS, Nair R, Tharyan P. Ovulation triggers in anovulatory women undergoing ovulation induction. Cochrane Database Syst Rev. 2014;1:CD006900.", "DOI": "10.1002/14651858.CD006900.pub3", "doi-asserted-by": "crossref"}, {"key": "12_CR109", "unstructured": "Fatum M, McVeigh E, Child T. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate. Hum Fertil (Camb). 2013;16(4):235\u2013240.", "DOI": "10.3109/14647273.2013.800650", "doi-asserted-by": "crossref"}, {"issue": "1", "key": "12_CR110", "first-page": "98", "volume": "40", "author": "C Yasa", "year": "2013", "unstructured": "Yasa C, Bastu E, Dural O, Celik E, Ergun B. Evaluation of low-dose letrozole addition to ovulation induction in IVF. Clin Exp Obstet Gynecol. 2013;40(1):98\u2013100.", "journal-title": "Clin Exp Obstet Gynecol"}, {"issue": "4", "key": "12_CR111", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/j.rbmo.2013.01.003", "volume": "26", "author": "LN Johnson", "year": "2013", "unstructured": "Johnson LN, Dillon KE, Sammel MD, Efymow BL, Mainigi MA, Dokras A, Gracia CR. Response to ovarian stimulation in patients facing gonadotoxic therapy. Reprod Biomed Online. 2013;26(4):337\u201344.", "journal-title": "Reprod Biomed Online"}, {"issue": "4", "key": "12_CR112", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1016/j.ogc.2012.09.008", "volume": "39", "author": "AM Propst", "year": "2012", "unstructured": "Propst AM, Bates GW Jr. Evaluation and treatment of anovulatory and unexplained infertility. Obstet Gynecol Clin North Am. 2012;39(4):507\u201319.", "journal-title": "Obstet Gynecol Clin North Am"}, {"issue": "2", "key": "12_CR113", "doi-asserted-by": "publisher", "first-page": "93", "DOI": "10.4103/0974-1208.117166", "volume": "6", "author": "S Kar", "year": "2013", "unstructured": "Kar S. Current evidence supporting \u201cletrozole\u201d for ovulation induction. J Hum Reprod Sci. 2013;6(2):93\u20138. doi:\n                  10.4103/0974-1208.117166\n                  \n                .", "journal-title": "J Hum Reprod Sci"}, {"issue": "2", "key": "12_CR114", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1056/NEJMoa1313517", "volume": "371", "author": "RS Legro", "year": "2014", "unstructured": "Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, Christman GM, Huang H, Yan Q, Alvero R, Haisenleder DJ, Barnhart KT, Bates GW, Usadi R, Lucidi S, Baker V, Trussell JC, Krawetz SA, Snyder P, Ohl D, Santoro N, Eisenberg E, Zhang H. NICHD Reproductive Medicine Network. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119\u201329.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "12_CR115", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1016/j.fertnstert.2012.10.023", "volume": "98", "author": "PN Schlegel", "year": "2012", "unstructured": "Schlegel PN. Aromatase inhibitors for male infertility. Fertil Steril. 2012;98(6):1359\u201362.", "journal-title": "Fertil Steril"}, {"issue": "6", "key": "12_CR116", "doi-asserted-by": "crossref", "first-page": "763", "DOI": "10.1016/j.contraception.2012.05.009", "volume": "86", "author": "TW Yeung", "year": "2012", "unstructured": "Yeung TW, Lee VC, Ng EH, Ho PC. A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days. Contraception. 2012;86(6):763\u20139.", "journal-title": "Contraception"}, {"issue": "4", "key": "12_CR117", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1016/j.contraception.2012.02.008", "volume": "86", "author": "H Kopp Kallner", "year": "2012", "unstructured": "Kopp Kallner H, Ho PC, Gemzell-Danielsson K. Effect of letrozole on uterine tonus and contractility: a randomized controlled trial. Contraception. 2012;86(4):419\u201324.", "journal-title": "Contraception"}, {"issue": "1", "key": "12_CR118", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1016/j.fertnstert.2008.04.042", "volume": "92", "author": "JA Garcia-Velasco", "year": "2009", "unstructured": "Garcia-Velasco JA, Quea G, Pir\u00f3 M, Mayoral M, Ruiz M, Toribio M. Requena A Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial. Fertil Steril. 2009;92(1):222\u20135.", "journal-title": "Fertil Steril"}, {"issue": "3", "key": "12_CR119", "first-page": "298", "volume": "11", "author": "M Fukami", "year": "2014", "unstructured": "Fukami M, Miyado M, Nagasaki K, Shozu M, Ogata T. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia. Pediatr Endocrinol Rev. 2014;11(3):298\u2013305.", "journal-title": "Pediatr Endocrinol Rev"}, {"issue": "4", "key": "12_CR120", "doi-asserted-by": "crossref", "first-page": "e280", "DOI": "10.3747/co.19.993", "volume": "19", "author": "MA Tunio", "year": "2012", "unstructured": "Tunio MA, Al-Asiri M, Al-Amro A, Bayoumi Y, Fareed M. Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis. Curr Oncol. 2012;19(4):e280\u20138.", "journal-title": "Curr Oncol"}, {"issue": "Suppl 1", "key": "12_CR121", "first-page": "57", "volume": "71", "author": "L Dunkel", "year": "2009", "unstructured": "Dunkel L. Update on the role of aromatase inhibitors in growth disorders. Horm Res. 2009;71(Suppl 1):57\u201363.", "journal-title": "Horm Res"}, {"key": "12_CR122", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1186/1477-7827-9-93", "volume": "9", "author": "W Ronde de", "year": "2011", "unstructured": "de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. 2011;9:93.", "journal-title": "Reprod Biol Endocrinol"}, {"issue": "3", "key": "12_CR123", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1038/nrendo.2011.161", "volume": "8", "author": "JM Wit", "year": "2011", "unstructured": "Wit JM, Hero M, Nunez SB. Aromatase inhibitors in pediatrics. Nat Rev Endocrinol. 2011;8(3):135\u201347.", "journal-title": "Nat Rev Endocrinol"}, {"issue": "2", "key": "12_CR124", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1016/j.ejogrb.2013.09.010", "volume": "171", "author": "N Duhan", "year": "2013", "unstructured": "Duhan N, Madaan S, Sen J. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):329\u201332.", "journal-title": "Eur J Obstet Gynecol Reprod Biol"}, {"key": "12_CR125", "unstructured": "Song H, Lu D, Navaratnam K, Shi G. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013;10:CD009505.", "DOI": "10.1002/14651858.CD009505.pub2", "doi-asserted-by": "crossref"}, {"issue": "2", "key": "12_CR126", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1530/REP-12-0386", "volume": "145", "author": "CN Olivares", "year": "2013", "unstructured": "Olivares CN, Bilotas MA, Ricci AG, Bara\u00f1ao RI, Meresman GF. Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? Reproduction. 2013;145(2):119\u201326.", "journal-title": "Reproduction"}, {"issue": "1", "key": "12_CR127", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1007/s00280-012-1977-9", "volume": "71", "author": "FJ Esteva", "year": "2013", "unstructured": "Esteva FJ, Moulder SL, Gonzalez-Angulo AM, Ensor J, Murray JL, Green MC, Koenig KB, Lee MH, Hortobagyi GN, Yeung SC. Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemother Pharmacol. 2013;71(1):63\u201372.", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "12_CR128", "unstructured": "Garcia-Giralt N, Rodr\u00edguez-Sanz M, Prieto-Alhambra D, Servitja S, Torres-Del Pliego E, Balcells S, Albanell J, Grinberg D, Diez-Perez A, Tusquets I, Nogu\u00e9s X. Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast Cancer Res Treat. 2013;140(2):385\u2013395.", "DOI": "10.1007/s10549-013-2638-3", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "12_CR129", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1007/s10549-013-2504-3", "volume": "138", "author": "NL Henry", "year": "2013", "unstructured": "Henry NL, Skaar TC, Dantzer J, Li L, Kidwell K, Gersch C, Nguyen AT, Rae JM, Desta Z, Oesterreich S, Philips S, Carpenter JS, Storniolo AM, Stearns V, Hayes DF, Flockhart DA. Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer. Breast Cancer Res Treat. 2013;138(3):807\u201316.", "journal-title": "Breast Cancer Res Treat"}, {"key": "12_CR130", "unstructured": "Berstein LM, Santen RJ (eds.) Innovative endocrinology of cancer. New York:Landes Bioscience/Springer Science+Business Media, LCC 2008. p. 262."}], "container-title": ["Resistance to Targeted Anti-Cancer Therapeutics", "Resistance to Aromatase Inhibitors in Breast Cancer"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-17972-8_12", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T22:49:04Z", "timestamp": 1559170144000}, "score": 44.768158, "issued": {"date-parts": [[2015]]}, "ISBN": ["9783319179711", "9783319179728"], "references-count": 130, "URL": "http://dx.doi.org/10.1007/978-3-319-17972-8_12", "relation": {"cites": []}, "ISSN": ["2196-5501", "2196-551X"], "issn-type": [{"value": "2196-5501", "type": "print"}, {"value": "2196-551X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T17:39:35Z", "timestamp": 1574357975603}, "reference-count": 32, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 9254, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Endocrinol"], "published-print": {"date-parts": [[1990, 5]]}, "DOI": "10.1111/j.1365-2265.1990.tb00906.x", "type": "journal-article", "created": {"date-parts": [[2008, 3, 17]], "date-time": "2008-03-17T12:06:14Z", "timestamp": 1205755574000}, "page": "623-634", "source": "Crossref", "is-referenced-by-count": 53, "title": ["POTENCY AND SELECTIVITY OF THE NON-STEROIDAL AROMATASE INHIBITOR CGS 16949A IN POSTMENOPAUSAL BREAST CANCER PATIENTS"], "prefix": "10.1111", "volume": "32", "author": [{"given": "M.", "family": "DOWSETT", "sequence": "first", "affiliation": []}, {"given": "R. C.", "family": "STEIN", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "MEHTA", "sequence": "additional", "affiliation": []}, {"given": "R. C.", "family": "COOMBES", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_317", "DOI": "10.1016/0039-128X(81)90087-8", "doi-asserted-by": "publisher"}, {"key": "b2_318", "DOI": "10.1016/S0140-6736(84)92795-8", "doi-asserted-by": "publisher"}, {"key": "b3_319", "DOI": "10.1007/BF00570496", "doi-asserted-by": "publisher"}, {"key": "b4_320", "author": "Dowsett M.", "volume": "58", "first-page": "99", "year": "1984", "journal-title": "Journal of Clinical Endocrinology and Metabolism", "DOI": "10.1210/jcem-58-1-99", "doi-asserted-by": "crossref"}, {"key": "b5_321", "author": "Dowsett M.", "volume": "23", "first-page": "303", "year": "1985", "journal-title": "Clinical Endocrinology", "DOI": "10.1111/j.1365-2265.1985.tb00228.x", "doi-asserted-by": "crossref"}, {"key": "b6_322", "author": "Dowsett M.", "volume": "52", "first-page": "525", "year": "1985", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1985.223", "doi-asserted-by": "crossref"}, {"key": "b7_323", "author": "Dowsett M.", "volume": "47", "first-page": "1957", "year": "1987", "journal-title": "Cancer Research"}, {"key": "b8_324", "author": "Dowsett M.", "volume": "49", "first-page": "1306", "year": "1989", "journal-title": "Cancer Research"}, {"key": "b9_325", "DOI": "10.1016/0026-0495(71)90109-0", "doi-asserted-by": "publisher"}, {"key": "b10_326", "author": "Ferguson K.", "volume": "19", "first-page": "358", "year": "1982", "journal-title": "Annals of Clinical Biochemistry", "DOI": "10.1177/000456328201900507", "doi-asserted-by": "crossref"}, {"key": "b11_327", "author": "Goss P. E.", "volume": "46", "first-page": "4823", "year": "1986", "journal-title": "Cancer Research"}, {"key": "b12_328", "author": "Harris A. L.", "volume": "55", "first-page": "718", "year": "1982", "journal-title": "Journal of Clinical Endocrinology and Metabolism", "DOI": "10.1210/jcem-55-4-718", "doi-asserted-by": "crossref"}, {"key": "b13_329", "DOI": "10.1016/0277-5379(83)90112-8", "doi-asserted-by": "publisher"}, {"key": "b14_330", "author": "Harris A. L.", "volume": "47", "first-page": "621", "year": "1983", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1983.100", "doi-asserted-by": "crossref"}, {"key": "b15_331", "author": "Harris A. L.", "volume": "48", "first-page": "585", "year": "1983", "journal-title": "British Journal of Cancer", "DOI": "10.1038/bjc.1983.232", "doi-asserted-by": "crossref"}, {"key": "b16_332", "author": "Hills M.", "volume": "8", "first-page": "7", "year": "1979", "journal-title": "British Journal of Clinical Pharmacology", "DOI": "10.1111/j.1365-2125.1979.tb05903.x", "doi-asserted-by": "crossref"}, {"key": "b17_333", "author": "Hughes S. W. M.", "volume": "46", "first-page": "409", "year": "1970", "journal-title": "Postgraduate Medical Journal", "DOI": "10.1136/pgmj.46.537.409", "doi-asserted-by": "crossref"}, {"key": "b18_334", "DOI": "10.1002/hlca.19660490113", "doi-asserted-by": "publisher"}, {"key": "b19_335", "author": "Kowal J.", "volume": "85", "first-page": "270", "year": "1969", "journal-title": "Endocrinology", "DOI": "10.1210/endo-85-2-270", "doi-asserted-by": "crossref"}, {"key": "b20_336", "author": "Murray R. M. L.", "first-page": "109", "year": "1984", "volume-title": "Treatment of Advanced Metastatic Breast Cancer, Carcinoma of the Prostate, and Endometrial Cancer with Aminoglutethimide"}, {"key": "b21_337", "author": "Nicholson R. I.", "first-page": "331", "year": "1987", "volume-title": "Hormonal Manipulation of Cancer: Peptides, Growth Factors, and New (Anti) Steroidal Agents"}, {"key": "b22_338", "DOI": "10.1001/jama.230.12.1661", "doi-asserted-by": "publisher"}, {"key": "b23_339", "author": "Santen R. J.", "volume": "47", "first-page": "1257", "year": "1978", "journal-title": "Journal of Clinical Endocrinology and Metabolism", "DOI": "10.1210/jcem-47-6-1257", "doi-asserted-by": "crossref"}, {"key": "b24_340", "author": "Santen R. J.", "volume": "68", "first-page": "99", "year": "1989", "journal-title": "Journal Clinical Endocrinology and Metabolism", "DOI": "10.1210/jcem-68-1-99", "doi-asserted-by": "crossref"}, {"key": "b25_341", "author": "Schieweck K.", "volume": "48", "first-page": "834", "year": "1988", "journal-title": "Cancer Research"}, {"key": "b26_342", "DOI": "10.1016/0039-128X(83)90068-5", "doi-asserted-by": "publisher"}, {"key": "b27_343", "unstructured": "R. C. Stein, M. Dowsett, J. Davenport, A. Hedley, and R. C. CoombesPreliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A, Cancer Research (in press)."}, {"key": "b28_344", "DOI": "10.1016/S0140-6736(84)90596-8", "doi-asserted-by": "publisher"}, {"key": "b29_345", "author": "Stuart-Harris R.", "volume": "22", "first-page": "219", "year": "1985", "journal-title": "Clinical Endocrinology", "DOI": "10.1111/j.1365-2265.1985.tb01083.x", "doi-asserted-by": "crossref"}, {"key": "b30_346", "DOI": "10.1016/0305-7372(84)90008-2", "doi-asserted-by": "publisher"}, {"key": "b31_347", "author": "Touitou Y.", "volume": "80", "first-page": "517", "year": "1975", "journal-title": "Acta Endocrinologica", "DOI": "10.1530/acta.0.0800517", "doi-asserted-by": "crossref"}, {"key": "b32_348", "author": "Vermeulen A. M.", "volume": "19", "first-page": "673", "year": "1983", "journal-title": "Clinical Endocrinology", "DOI": "10.1111/j.1365-2265.1983.tb00044.x", "doi-asserted-by": "crossref"}], "container-title": ["Clinical Endocrinology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1990.tb00906.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T11:21:48Z", "timestamp": 1549711308000}, "score": 44.049725, "issued": {"date-parts": [[1990, 5]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[1990, 5]]}, "issue": "5"}, "alternative-id": ["10.1111/j.1365-2265.1990.tb00906.x"], "URL": "http://dx.doi.org/10.1111/j.1365-2265.1990.tb00906.x", "relation": {"cites": []}, "ISSN": ["0300-0664", "1365-2265"], "issn-type": [{"value": "0300-0664", "type": "print"}, {"value": "1365-2265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:11:14Z", "timestamp": 1574799074223}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 2, 15]]}, "DOI": "10.1158/1538-7445.sabcs15-p3-07-40", "type": "proceedings-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T08:48:00Z", "timestamp": 1463734080000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P3-07-40: Pharmacogenetic study of exemestane and everolimus in metastatic breast cancer patients progressing on prior non-steroidal aromatase inhibitors"], "prefix": "10.1158", "author": [{"given": "T", "family": "Pascual-Mart\u00ednez", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Apell\u00e1niz-Ruiz", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Pernaut", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Cueto-Felgueroso", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Villalba", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Alvarez", "sequence": "additional", "affiliation": []}, {"given": "L", "family": "Manso", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Rodriguez-Antona", "sequence": "additional", "affiliation": []}, {"given": "EM", "family": "Ciruelos", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 2, 18]]}, "event": {"name": "Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.SABCS15-P3-07-40", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T16:53:44Z", "timestamp": 1558198424000}, "score": 43.929523, "issued": {"date-parts": [[2016, 2, 15]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.SABCS15-P3-07-40"], "URL": "http://dx.doi.org/10.1158/1538-7445.sabcs15-p3-07-40"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T03:20:53Z", "timestamp": 1574738453254}, "reference-count": 37, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2015, 10, 24]], "date-time": "2015-10-24T00:00:00Z", "timestamp": 1445644800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/100004339", "name": "Sanofi", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2015, 11]]}, "DOI": "10.1007/s10549-015-3615-9", "type": "journal-article", "created": {"date-parts": [[2015, 10, 25]], "date-time": "2015-10-25T00:54:21Z", "timestamp": 1445734461000}, "page": "287-297", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor"], "prefix": "10.1007", "volume": "154", "author": [{"given": "Kimberly", "family": "Blackwell", "sequence": "first", "affiliation": []}, {"given": "Howard", "family": "Burris", "sequence": "additional", "affiliation": []}, {"given": "Patricia", "family": "Gomez", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Lynn Henry", "sequence": "additional", "affiliation": []}, {"given": "Steven", "family": "Isakoff", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Campana", "sequence": "additional", "affiliation": []}, {"given": "Lei", "family": "Gao", "sequence": "additional", "affiliation": []}, {"given": "Jason", "family": "Jiang", "sequence": "additional", "affiliation": []}, {"given": "Sandrine", "family": "Mac\u00e9", "sequence": "additional", "affiliation": []}, {"given": "Sara M.", "family": "Tolaney", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 10, 24]]}, "reference": [{"key": "3615_CR1", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1309/4WV79N2GHJ3X1841", "volume": "123", "author": "M Nadji", "year": "2005", "unstructured": "Nadji M, Gomez-Fernandez C, Ganjei-Azar P, Morales AR (2005) Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5993 breast cancers. Am J Clin Pathol 123:21\u201327", "journal-title": "Am J Clin Pathol"}, {"key": "3615_CR2", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1056/NEJM200101253440407", "volume": "344", "author": "M Clemons", "year": "2001", "unstructured": "Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344:276\u2013285", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "3615_CR3", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1634/theoncologist.9-suppl_3-20", "volume": "9", "author": "M Ellis", "year": "2004", "unstructured": "Ellis M (2004) Overcoming endocrine therapy resistance by signal transduction inhibition. Oncologist 9(3):20\u201326", "journal-title": "Oncologist"}, {"key": "3615_CR4", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1200/JCO.20.3.751", "volume": "20", "author": "J Geisler", "year": "2002", "unstructured": "Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20:751\u2013757", "journal-title": "J Clin Oncol"}, {"key": "3615_CR5", "doi-asserted-by": "crossref", "first-page": "1075", "DOI": "10.1200/JCO.2009.25.3641", "volume": "28", "author": "KD Courtney", "year": "2010", "unstructured": "Courtney KD, Corcoran RB, Engelman JA (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075\u20131083", "journal-title": "J Clin Oncol"}, {"key": "3615_CR6", "doi-asserted-by": "crossref", "first-page": "6084", "DOI": "10.1158/0008-5472.CAN-07-6854", "volume": "68", "author": "K Stemke-Hale", "year": "2008", "unstructured": "Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, Neve RM, Kuo WL, Davies M, Carey M, Hu Z, Guan Y, Sahin A, Symmans WF, Pusztai L, Nolden LK, Horlings H, Berns K, Hung MC, van de Vijver MJ, Valero V, Gray JW, Bernards R, Mills GB, Hennessy BT (2008) An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 68:6084\u20136091", "journal-title": "Cancer Res"}, {"key": "3615_CR7", "unstructured": "The Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61\u201370", "DOI": "10.1038/nature11412", "doi-asserted-by": "crossref"}, {"key": "3615_CR8", "doi-asserted-by": "crossref", "first-page": "2554", "DOI": "10.1158/0008-5472-CAN-04-3913", "volume": "65", "author": "LH Saal", "year": "2005", "unstructured": "Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmstrom PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A, Parsons R (2005) PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 65:2554\u20132559", "journal-title": "Cancer Res"}, {"key": "3615_CR9", "doi-asserted-by": "crossref", "first-page": "353", "DOI": "10.1038/nature11143", "volume": "486", "author": "MJ Ellis", "year": "2012", "unstructured": "Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER (2012) Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486:353\u2013360", "journal-title": "Nature"}, {"key": "3615_CR10", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1038/ncponc1179", "volume": "5", "author": "A Prat", "year": "2008", "unstructured": "Prat A, Baselga J (2008) The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat Clin Pract Oncol 5:531\u2013542", "journal-title": "Nat Clin Pract Oncol"}, {"key": "3615_CR11", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1186/bcr3039", "volume": "13", "author": "TW Miller", "year": "2011", "unstructured": "Miller TW, Rexer BN, Garrett JT, Arteaga CL (2011) Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 13:224", "journal-title": "Breast Cancer Res"}, {"key": "3615_CR12", "doi-asserted-by": "crossref", "first-page": "4724", "DOI": "10.1158/0008-5472.CAN-08-4194", "volume": "69", "author": "I Barone", "year": "2009", "unstructured": "Barone I, Cui Y, Herynk MH, Corona-Rodriguez A, Giordano C, Selever J, Beyer A, Ando S, Fuqua SA (2009) Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway. Cancer Res 69:4724\u20134732", "journal-title": "Cancer Res"}, {"key": "3615_CR13", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1016/j.canlet.2012.03.034", "volume": "323", "author": "A Cavazzoni", "year": "2012", "unstructured": "Cavazzoni A, Bonelli MA, Fumarola C, La Monica S, Airoud K, Bertoni R, Alfieri RR, Galetti M, Tramonti S, Galvani E, Harris AL, Martin LA, Andreis D, Bottini A, Generali D, Petronini PG (2012) Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. Cancer Lett 323:77\u201387", "journal-title": "Cancer Lett"}, {"key": "3615_CR14", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.1056/NEJMoa1109653", "volume": "366", "author": "J Baselga", "year": "2012", "unstructured": "Baselga J, Campone M, Piccart M, Burris HA III, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN (2012) Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med 366:520\u2013529", "journal-title": "N Engl J Med"}, {"key": "3615_CR15", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1200/JCO.2011.38.3331", "volume": "31", "author": "AC Wolff", "year": "2013", "unstructured": "Wolff AC, Lazar AA, Bondarenko I, Garin AM, Brincat S, Chow L, Sun Y, Neskovic-Konstantinovic Z, Guimaraes RC, Fumoleau P, Chan A, Hachemi S, Strahs A, Cincotta M, Berkenblit A, Krygowski M, Kang LL, Moore L, Hayes DF (2013) Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. J Clin Oncol 31:195\u2013202", "journal-title": "J Clin Oncol"}, {"key": "3615_CR16", "doi-asserted-by": "crossref", "first-page": "1202", "DOI": "10.1200/JCO.2013.54.0518", "volume": "32", "author": "IA Mayer", "year": "2014", "unstructured": "Mayer IA, Abramson VG, Isakoff SJ, Forero A, Balko JM, Kuba MG, Sanders ME, Yap JT, Van den Abbeele AD, Li Y, Cantley LC, Winer E, Arteaga CL (2014) Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. J Clin Oncol 32:1202\u20131209", "journal-title": "J Clin Oncol"}, {"key": "3615_CR17", "unstructured": "Krop I, Johnston S, Mayer IA, Dickler M, Ganju V, Forero-Torres A, Melichar B, Morales S, de Boer R, Gendreau S, Derynck M, Lackner M, Spoerke J, Yeh R-F, Levy G, Ng V, O\u2019Brien C, Savage H, Xiao Y, Wilson T, Lee SC, Petrakova K, Vallentin S, Yardley D, Ellis M, Piccart M, Perez EA, Winer E, Schmid P (2014) The FERGI phase II study of the PI3K inhibitor pictilisib (GDC-0941) plus fulvestrant vs fulvestrant plus placebo in patients with ER+, aromatase inhibitor (AI)-resistant advanced or metastatic breast cancer\u2014part I results. San Antonio Breast Cancer Symposium (SABCS) 2014: abstract S2-02"}, {"key": "3615_CR18", "unstructured": "Piccart M, Hortobagyi GN, Campone M, Pritchard KI, Lebrun F, Ito Y, Noguchi S, Perez A, Rugo HS, Deleu I, Burris HA III, Provencher L, Neven P, Gnant M, Shtivelband M, Wu C, Fan J, Feng W, Taran T, Baselga J (2014) Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2. Ann Oncol 25:2357\u20132362", "DOI": "10.1093/annonc/mdu456", "doi-asserted-by": "crossref"}, {"key": "3615_CR19", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1158/1078-0432.CCR-13-1777", "volume": "20", "author": "GI Shapiro", "year": "2014", "unstructured": "Shapiro GI, Rodon J, Bedell C, Kwak EL, Baselga J, Brana I, Pandya SS, Scheffold C, Laird AD, Nguyen LT, Xu Y, Egile C, Edelman G (2014) Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245408 (XL147), an oral pan-class I PI3K inhibitor, in patients with advanced solid tumors. Clin Cancer Res 20:233\u2013245", "journal-title": "Clin Cancer Res"}, {"key": "3615_CR20", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1634/theoncologist.2014-0449", "volume": "20", "author": "JC Soria", "year": "2015", "unstructured": "Soria JC, LoRusso P, Bahleda R, Lager J, Liu L, Jiang J, Martini JF, Mace S, Burris H (2015) Phase I dose-escalation study of pilaralisib (SAR245408, XL147), a pan-class I PI3K inhibitor, in combination with erlotinib in patients with solid tumors. Oncologist 20:245\u2013246", "journal-title": "Oncologist"}, {"key": "3615_CR21", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1016/j.ygyno.2014.12.019", "volume": "136", "author": "U Matulonis", "year": "2015", "unstructured": "Matulonis U, Vergote I, Backes F, Martin LP, McMeekin S, Birrer M, Campana F, Xu Y, Egile C, Ghamande S (2015) Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma. Gynecol Oncol 136:246\u2013253", "journal-title": "Gynecol Oncol"}, {"key": "3615_CR22", "doi-asserted-by": "crossref", "first-page": "3160", "DOI": "10.1158/1078-0432.CCR-14-3262", "volume": "21", "author": "JR Brown", "year": "2015", "unstructured": "Brown JR, Davids MS, Rodon J, Abrisqueta P, Kasar SN, Lager J, Jiang J, Egile C, Awan FT (2015) Phase I trial of the pan-PI3K inhibitor pilaralisib (SAR245408/XL147) in patients with chronic lymphocytic leukemia (CLL) or relapsed/refractory lymphoma. Clin Cancer Res 21:3160\u20133169", "journal-title": "Clin Cancer Res"}, {"key": "3615_CR23", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1007/s10549-014-3248-4", "volume": "149", "author": "S Tolaney", "year": "2015", "unstructured": "Tolaney S, Burris H, Gartner E, Mayer IA, Saura C, Maurer M, Ciruelos E, Garcia AA, Campana F, Wu B, Xu Y, Jiang J, Winer E, Krop I (2015) Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer. Breast Cancer Res Treat 149:151\u2013161", "journal-title": "Breast Cancer Res Treat"}, {"key": "3615_CR24", "doi-asserted-by": "crossref", "first-page": "2445", "DOI": "10.1158/1078-0432.CCR-13-2403", "volume": "20", "author": "K Papadopoulos", "year": "2014", "unstructured": "Papadopoulos K, Tabernero J, Markman B, Patnaik A, Tolcher A, Baselga J, Shi W, Egile C, Ruiz-Soto R, Laird AD, Miles D, Lorusso PM (2014) Phase I safety, pharmacokinetic and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors. Clin Cancer Res 20:2445\u20132456", "journal-title": "Clin Cancer Res"}, {"key": "3615_CR25", "unstructured": "Wen PY, Omuro A, Ahluwalia MS, Fathallah-Shaykh HM, Mohile N, Lager JJ, Laird AD, Tang J, Jiang J, Egile C, Cloughesy TF (2015) Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma. Neuro Oncol. Epub ahead of print", "DOI": "10.1093/neuonc/nov083", "doi-asserted-by": "crossref"}, {"key": "3615_CR26", "doi-asserted-by": "crossref", "first-page": "316", "DOI": "10.1097/JTO.0000000000000088", "volume": "9", "author": "PA Janne", "year": "2014", "unstructured": "Janne PA, Cohen RB, Laird AD, Mace S, Engelman JA, Ruiz-Soto R, Rockich K, Xu J, Shapiro GI, Martinez P, Felip E (2014) Phase I safety and pharmacokinetic study of the PI3K/mTOR inhibitor SAR245409 (XL765) in combination with erlotinib in patients with advanced solid tumors. J Thorac Oncol 9:316\u2013323", "journal-title": "J Thorac Oncol"}, {"key": "3615_CR27", "first-page": "86", "volume": "122", "author": "JR Brown", "year": "2013", "unstructured": "Brown JR, Hamadani M, Arnason J, Karlin L, Hayslip J, Wagner-Johnston N, Cartron G, Ribrag V, de Guibert S, Opat S, Tilly H, Cannell P, Janssens A, Offner F, Ganguly S, Ailawadhi S, Millenson M, Bron D, Xu Y, Ruiz-Soto R, Kersten MJ (2013) SAR245409 monotherapy in relapsed/refractory follicular lymphoma: preliminary results from the phase II ARD12130 study. Blood 122:86", "journal-title": "Blood"}, {"key": "3615_CR28", "doi-asserted-by": "crossref", "first-page": "1763", "DOI": "10.3109/10428194.2014.974040", "volume": "56", "author": "KP Papadopoulos", "year": "2014", "unstructured": "Papadopoulos KP, Egile C, Ruiz-Soto R, Jiang J, Shi W, Bentzien F, Rasco D, Abrisqueta P, Vose JM, Tabernero J (2014) Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma. Leuk Lymphoma 56:1763\u20131770", "journal-title": "Leuk Lymphoma"}, {"key": "3615_CR29", "doi-asserted-by": "crossref", "first-page": "228", "DOI": "10.1016/j.ejca.2008.10.026", "volume": "45", "author": "EA Eisenhauer", "year": "2009", "unstructured": "Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247", "journal-title": "Eur J Cancer"}, {"key": "3615_CR30", "unstructured": "National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 3.0. 2006. http://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf"}, {"key": "3615_CR31", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.ejca.2007.10.003", "volume": "44", "author": "A Awada", "year": "2008", "unstructured": "Awada A, Cardoso F, Fontaine C, Dirix L, De Greve J, Sotiriou C, Steinseifer J, Wouters C, Tanaka C, Zoellner U, Tang P, Piccart M (2008) The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics. Eur J Cancer 44:84\u201391", "journal-title": "Eur J Cancer"}, {"key": "3615_CR32", "unstructured": "Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, Butler A, Cheverton A, Gamble J, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, Lau KW, McLaren S, McBride DJ, Menzies A, Mudie L, Raine K, Rad R, Chapman MS, Teague J, Easton D, Langerod A, Lee MT, Shen CY, Tee BT, Huimin BW, Broeks A, Vargas AC, Turashvili G, Martens J, Fatima A, Miron P, Chin SF, Thomas G, Boyault S, Mariani O, Lakhani SR, van d, V, van \u2018, V, Foekens J, Desmedt C, Sotiriou C, Tutt A, Caldas C, Reis-Filho JS, Aparicio SA, Salomon AV, Borresen-Dale AL, Richardson AL, Campbell PJ, Futreal PA, Stratton MR (2012) The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400\u2013404", "DOI": "10.1038/nature11017", "doi-asserted-by": "crossref"}, {"key": "3615_CR33", "first-page": "4170", "volume": "122", "author": "JR Brown", "year": "2013", "unstructured": "Brown JR, Davids MS, Rodon J, Abrisqueta P, Egile C, Ruiz-Soto R, Awan F (2013) Update on the safety and efficacy of the pan class I PI3K inhibitor SAR245408 (XL147) in chronic lymphocytic leukemia and non-Hodgkin\u2019s lymphoma patients. Blood 122:4170", "journal-title": "Blood"}, {"key": "3615_CR34", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1158/1078-0432.CCR-13-1070", "volume": "20", "author": "C Saura", "year": "2014", "unstructured": "Saura C, Bendell J, Jerusalem G, Su S, Ru Q, De Buck S, Mills D, Ruquet S, Bosch A, Urruticoechea A, Beck JT, Di Tomaso E, Sternberg DW, Massacesi C, Hirawat S, Dirix L, Baselga J (2014) Phase Ib study of buparlisib plus trastuzumab in patients with HER2-positive advanced or metastatic breast cancer that has progressed on trastuzumab-based therapy. Clin Cancer Res 20:1935\u20131945", "journal-title": "Clin Cancer Res"}, {"key": "3615_CR35", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1200/JCO.2011.36.1360", "volume": "30", "author": "C Bendell", "year": "2012", "unstructured": "Bendell C, Rodon J, Burris HA, de Jonge M, Verweij J, Birle D, Demanse D, De Buck SS, Ru QC, Peters M, Goldbrunner M, Baselga J (2012) Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. J Clin Oncol 30:282\u2013290", "journal-title": "J Clin Oncol"}, {"key": "3615_CR36", "doi-asserted-by": "crossref", "first-page": "2399", "DOI": "10.1093/annonc/mds011", "volume": "23", "author": "B Markman", "year": "2012", "unstructured": "Markman B, Tabernero J, Krop I, Shapiro GI, Siu L, Chen LC, Mita M, Melendez CM, Stutvoet S, Birle D, Anak O, Hackl W, Baselga J (2012) Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. Ann Oncol 23:2399\u20132408", "journal-title": "Ann Oncol"}, {"key": "3615_CR37", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1007/s10637-014-0082-9", "volume": "32", "author": "J Rodon", "year": "2014", "unstructured": "Rodon J, Brana I, Siu LL, De Jonge MJ, Homji N, Mills D, Di Tomaso E, Sarr C, Trandafir L, Massacesi C, Eskens F, Bendell JC (2014) Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. Invest New Drugs 32:670\u2013681", "journal-title": "Invest New Drugs"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10549-015-3615-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10549-015-3615-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-015-3615-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 31]], "date-time": "2019-08-31T22:46:33Z", "timestamp": 1567291593000}, "score": 43.002293, "issued": {"date-parts": [[2015, 10, 24]]}, "references-count": 37, "journal-issue": {"published-print": {"date-parts": [[2015, 11]]}, "issue": "2"}, "alternative-id": ["3615"], "URL": "http://dx.doi.org/10.1007/s10549-015-3615-9", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:15:55Z", "timestamp": 1574111755868}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001, 11]]}, "DOI": "10.1023/a:1013180214359", "type": "journal-article", "created": {"date-parts": [[2002, 12, 23]], "date-time": "2002-12-23T20:50:38Z", "timestamp": 1040676638000}, "page": "1539-1543", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?"], "prefix": "10.1093", "volume": "12", "author": [{"given": "P.", "family": "Carlini", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Frassoldati", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "De Marco", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Casali", "sequence": "additional", "affiliation": []}, {"given": "E. M.", "family": "Ruggeri", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Nardi", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Papaldo", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Fabi", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Paoloni", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Cognetti", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2001, 11]]}, "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/12/11/1539/19478880/12-11-1539.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T13:55:56Z", "timestamp": 1503410156000}, "score": 42.78481, "issued": {"date-parts": [[2001, 11]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2001, 11]]}, "published-print": {"date-parts": [[2001, 11]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1023/a:1013180214359", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:00:23Z", "timestamp": 1574524823057}, "publisher-location": "Basel", "reference-count": 15, "publisher": "Birkh\u00e4user Basel", "isbn-type": [{"value": "9783764317508", "type": "print"}, {"value": "9783034877206", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1985]]}, "DOI": "10.1007/978-3-0348-7720-6_16", "type": "book-chapter", "created": {"date-parts": [[2012, 12, 30]], "date-time": "2012-12-30T07:21:21Z", "timestamp": 1356852081000}, "page": "135-140", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the Elderly"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Orme", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "16_CR1", "author": "K O\u2019Malley", "first-page": "3", "year": "1971", "unstructured": "O\u2019Malley, K., Crooks, J., Duke, E., Stevenson, I.H. (1971). Brit. Med. J. 3, 507\u2013509.", "volume-title": "Brit"}, {"key": "16_CR2", "author": "RC Hamdy", "first-page": "5", "year": "1982", "unstructured": "Hamdy, R.C., Murnane, B., Perera, N., Woodcock, K., Koch, I.M. (1982). Eur. J. Rheumatol. Inflamm. 5, 69\u201375.", "volume-title": "Eur. J"}, {"key": "16_CR3", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1159/000212320", "volume": "25", "author": "G Cuny", "year": "1979", "unstructured": "Cuny, G., Roger, R.J., Mur, S.M., Serot, J.M., Netter, F.P., Maillard, A., Penin F. (1979). Gerontology, 25, 49\u201355.", "journal-title": "Gerontology"}, {"key": "16_CR4", "author": "S Wallace", "first-page": "3", "year": "1976", "unstructured": "Wallace, S., Whiting, B. (1976). Brit. J. Clin. Pharmacol. 3, 327\u2013330.", "volume-title": "Brit. J"}, {"key": "16_CR5", "first-page": "151", "volume": "27", "author": "A Traeger", "year": "1973", "unstructured": "Traeger, A., Kunze, M., Stein, G., Ankermann, H. (1973). Z. Alternforsch. 27, 151\u2013155.", "journal-title": "Z. Alternforsch"}, {"key": "16_CR6", "author": "C Advenier", "first-page": "16", "year": "1983", "unstructured": "Advenier, C., Roux, A., Gobert, C., Massias, P., Varoquaux, 0., Floutat, B., (1983). Brit. J. Clin. Pharmacol. 16, 65\u201380.", "volume-title": "Brit. J"}, {"key": "16_CR7", "author": "AE Ritch", "first-page": "14", "year": "1982", "unstructured": "Ritch, A.E., Perera, W.N., Jones, C.J., (1982). Brit. J. Clin. Pharmacol. 14, 116\u2013119.", "volume-title": "Brit. J"}, {"key": "16_CR8", "author": "AD Woolf", "first-page": "16", "year": "1983", "unstructured": "Woolf, A.D., Rogers, H.J., Bradbrook, I.D., Corless, D. (1983). Brit. J. Clin. Pharmacol. 16, 433\u2013437.", "volume-title": "Brit. J"}, {"key": "16_CR9", "author": "JV Willis", "first-page": "22", "year": "1978", "unstructured": "Willis, J.V., Kendall, M.J. (1978) Scand. J. Rheumatol. ( Suppl ) 22, 36\u201341.", "volume-title": "Scand. J"}, {"key": "16_CR10", "author": "RA Upton", "first-page": "18", "year": "1984", "unstructured": "Upton, R.A., Williams, R.L., Kelly, J., Jones, R.M. (1984). Brit. J. Clin. Pharmacol. 18, 207\u2013214.", "volume-title": "Brit. J"}, {"key": "16_CR11", "doi-asserted-by": "publisher", "first-page": "1066", "DOI": "10.1002/art.1780270918", "volume": "27", "author": "D Greenblatt", "year": "1984", "unstructured": "Greenblatt, D., Abernethy, D.R., Matlis, R., Harmatz, J.S., Shader, R.I., (1984) Arthr. Rheum. 27, 1066\u20131069.", "journal-title": "Arthr. Rheum"}, {"key": "16_CR12", "author": "DJ Greenblatt", "first-page": "19", "year": "1985", "unstructured": "Greenblatt, D.J., Matlis, R., Scavone, J.M., Blyden, G.T., Harmatz, J.S., Shader, R.I., (1985) Brit. J. Clin. Pharmacol. 19, 373\u2013378.", "volume-title": "Brit. J"}, {"key": "16_CR13", "author": "DJ Greenblatt", "first-page": "40", "year": "1983", "unstructured": "Greenblatt, D.J., Divoll, M., Abernethy, D.R., Moschitto, L.J., Smith, R.B., Shader, R.I. (1983). Arch. Gen. Psychiatry. 40, 287\u2013290.", "volume-title": "Arch"}, {"key": "16_CR14", "author": "DJ Greenblatt", "first-page": "30", "year": "1981", "unstructured": "Greenblatt, D.J., Divoll, M., Harmatz, J.S., MacLaughlin, D.S., Shader, R.I., (1981). Clin. Pharmacol. Ther. 30, 475\u2013486.", "volume-title": "Clin"}, {"key": "16_CR15", "author": "CJ Richardson", "first-page": "37", "year": "1985", "unstructured": "Richardson, C.J., Blocka, K.L.N., Ross, R.T., Verbeeck, R.K. (1985). Clin. Pharmacol. Ther. 37, 13\u201318.", "volume-title": "Clin"}], "container-title": ["Non-steroidal Anti-Inflammatory Drugs Basis for Variability in Response"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-0348-7720-6_16", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 10]], "date-time": "2019-05-10T02:57:42Z", "timestamp": 1557457062000}, "score": 42.17381, "issued": {"date-parts": [[1985]]}, "ISBN": ["9783764317508", "9783034877206"], "references-count": 15, "URL": "http://dx.doi.org/10.1007/978-3-0348-7720-6_16", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T04:19:22Z", "timestamp": 1575260362212}, "publisher-location": "Basel", "reference-count": 36, "publisher": "Birkh\u00e4user Basel", "isbn-type": [{"value": "9783034857246", "type": "print"}, {"value": "9783034857222", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1992]]}, "DOI": "10.1007/978-3-0348-5722-2_4", "type": "book-chapter", "created": {"date-parts": [[2013, 8, 7]], "date-time": "2013-08-07T08:34:44Z", "timestamp": 1375864484000}, "page": "41-50", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Non-Steroidal Anti-Inflammatory Drugs: Epidemiological Studies of Adverse Reactions"], "prefix": "10.1007", "author": [{"given": "M.", "family": "Levy", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "4_CR1", "author": "D Slone", "first-page": "59", "year": "1977", "unstructured": "Slone, D., Shapiro, S., and Miettinen, O.S., Case-control surveillance of serious illnesses attributable to ambulatory drug use. In: Colombo, F., Shapiro, S., Slone, D., and Tognoni, G., (Eds.), Epidemiological evaluation of drugs. PSG Publishing Co., Littleton, MA 1977, p. 59.", "volume-title": "Epidemiological evaluation of drugs"}, {"key": "4_CR2", "author": "WH Inman", "year": "1979", "unstructured": "Inman, W.H., Recorded release. In: Gross, F. H. and Inman, W. H., (Eds.), Drug monitoring. Academic Press, London 1979.", "volume-title": "Drug monitoring"}, {"key": "4_CR3", "first-page": "541", "volume": "1", "author": "Royal College of General Practitioners\u2019 Oral Contraceptive Study", "year": "1981", "unstructured": "Royal College of General Practitioners\u2019 Oral Contraceptive Study, Further analyses of mortality on oral contraceptive users, 1, 541 (1981).", "journal-title": "Further analyses of mortality on oral contraceptive users"}, {"key": "4_CR4", "first-page": "163", "volume": "3", "author": "K Giercksky", "year": "1989", "unstructured": "Giercksky, K., Huseby, G., and Rugstad, H. E., Epidemiology of NSAID-related gastrointestinal side-effects. Scand. J. Gastroenterol 163, suppl.: 3 (1989).", "journal-title": "Scand. J. Gastroenterol"}, {"key": "4_CR5", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1016/0021-9681(79)90006-7", "volume": "32", "author": "P Cole", "year": "1979", "unstructured": "Cole, P., The evolving case-control study. J. Chr. Dis. 32: 15 (1979).", "journal-title": "J. Chr. Dis"}, {"key": "4_CR6", "author": "JJ Schlesselman", "first-page": "40", "year": "1982", "unstructured": "Schlesselman, J.J., Case-control studies: design, conduct, analysis. Oxford University Press, New York 1982, p. 40.", "volume-title": "Case-control studies: design, conduct, analysis"}, {"key": "4_CR7", "author": "B MacMahon", "year": "1970", "unstructured": "MacMahon, B. and Pugh, T.F., Epidemiology: principles and methods. Little, Brown, Boston 1970.", "volume-title": "Epidemiology: principles and methods"}, {"key": "4_CR8", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1007/BF03259953", "volume": "2", "author": "PD Fowler", "year": "1987", "unstructured": "Fowler, P.D., Aspirin, paracetamol and non-steroidal anti-inflammatory drugs: a comparative review of side effects. Med. Toxicol. 2: 338 (1987).", "journal-title": "Med. Toxicol"}, {"key": "4_CR9", "doi-asserted-by": "publisher", "first-page": "278", "DOI": "10.1136/bmj.300.6720.278", "volume": "300", "author": "CJ Hawkey", "year": "1990", "unstructured": "Hawkey, C.J., Non-steroidal anti-inflammatory drugs and peptic ulcers. Br. Med. J. 300: 278 (1990).", "journal-title": "Br. Med. J."}, {"key": "4_CR10", "first-page": "177", "volume": "4", "author": "M Levy", "year": "1990", "unstructured": "Levy, M. and Heyman, A., Hematological adverse effects of analgesic anti-inflammatory drugs. Hematol. Rev., 4: 177 (1990).", "journal-title": "Hematol. Rev."}, {"key": "4_CR11", "doi-asserted-by": "publisher", "first-page": "395", "DOI": "10.1111/j.1365-2125.1980.tb01829.x", "volume": "10", "author": "M Levy", "year": "1980", "unstructured": "Levy, M., Epidemiological evaluation of rare side-effects of mild analgesics. Br. J. Clin. Pharmacol. 10: 395s (1980).", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "4_CR12", "doi-asserted-by": "publisher", "first-page": "1143", "DOI": "10.1136/bmj.1.4038.1143", "volume": "1", "author": "AH Douthwaite", "year": "1938", "unstructured": "Douthwaite, A.H., Some recent advancees in medical diagnosis and treatment. Br. Med. J. 1: 1143 (1938).", "journal-title": "Br. Med. J."}, {"key": "4_CR13", "author": "M Levy", "first-page": "100", "year": "1987", "unstructured": "Levy, M., The epidemiological evaluation of major upper gastrointestinal bleeding in relation to aspirin use. In: Kewitz, H., Roots, I., and Voigt, K., (Eds.), The epidemiological concepts of clinical pharmacology. Springer Verlag, Berlin 1987, p. 100.", "volume-title": "The epidemiological concepts of clinical pharmacology", "DOI": "10.1007/978-3-642-71043-8_11", "doi-asserted-by": "publisher"}, {"key": "4_CR14", "doi-asserted-by": "publisher", "first-page": "1158", "DOI": "10.1056/NEJM197405232902102", "volume": "290", "author": "M Levy", "year": "1974", "unstructured": "Levy, M., Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N. Engl. J. Med. 290: 1158 (1974).", "journal-title": "N. Engl. J. Med"}, {"key": "4_CR15", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.1136/gut.23.4.340", "volume": "23", "author": "D Coggon", "year": "1982", "unstructured": "Coggon, D., Langman, M.J.S., and Spiegelhalter, D., Aspirin, paracetamol and haemateme-sis and melena. Gut 23: 340 (1982).", "journal-title": "Gut"}, {"key": "4_CR16", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1001/archinte.1988.00380020025005", "volume": "148", "author": "M Levy", "year": "1988", "unstructured": "Levy, M., Miller, D.R., Kaufman, D.W. et al., Major upper gastrointestinal bleeding. Relation to the use of aspirin and other non-narcotic analgesics. Arch. Intern. Med. 148:281 (1988).", "journal-title": "Arch. Intern. Med"}, {"key": "4_CR17", "author": "DW Kaufman", "year": "1990", "unstructured": "Kaufman, D.W., personal communication (1990).", "volume-title": "Personal Communication"}, {"key": "4_CR18", "doi-asserted-by": "publisher", "first-page": "1311", "DOI": "10.1136/bmj.297.6659.1311", "volume": "297", "author": "G Faulkner", "year": "1988", "unstructured": "Faulkner, G., Prichard, R, Somerville, K., and Langman, M.J.S., Aspirin and bleeding peptic ulcers in the elderly. Br. Med. J. 297: 1311 (1988).", "journal-title": "Br. Med. J"}, {"key": "4_CR19", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1001/jama.1980.03300330019023", "volume": "243", "author": "Aspirin Myocardial Infarction Study Research Group", "year": "1980", "unstructured": "Aspirin Myocardial Infarction Study Research Group, A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. J. Am. Med. Assn. 243:661 (1980).", "journal-title": "J. Am. Med. Assn"}, {"key": "4_CR20", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1161/01.CIR.62.3.449", "volume": "62", "author": "Persantine-Aspirin Reinfarction Study Research Group", "year": "1980", "unstructured": "Persantine-Aspirin Reinfarction Study Research Group, Persantine and aspirin in coronary heart disease. Circulation 62: 449 (1980).", "journal-title": "Circulation"}, {"key": "4_CR21", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1056/NEJM198907203210301", "volume": "321", "author": "Steering Committee of the Physicians\u2019 Health Study Research Group", "year": "1989", "unstructured": "Steering Committee of the Physicians\u2019 Health Study Research Group, Final report on the aspirin component of the ongoing Physicians\u2019 Health Study. N. Engl. J. Med. 321: 129 (1989).", "journal-title": "N. Engl. J. Med."}, {"key": "4_CR22", "doi-asserted-by": "publisher", "first-page": "462", "DOI": "10.1016/S0140-6736(86)92927-2", "volume": "i", "author": "K Sommerville", "year": "1986", "unstructured": "Sommerville, K., Faulkner, G., and Langman, M.J.S., Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet, i, 462 (1986).", "journal-title": "Lancet"}, {"key": "4_CR23", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.7326/0003-4819-109-5-359", "volume": "109", "author": "MR Griffin", "year": "1988", "unstructured": "Griffin, M.R., Ray, W A., and Schaffner, W., Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann. Intern. Med. 109: 359 (1988).", "journal-title": "Ann. Intern. Med"}, {"key": "4_CR24", "doi-asserted-by": "publisher", "first-page": "892", "DOI": "10.1136/pgmj.65.770.892", "volume": "65", "author": "EH Smedley", "year": "1989", "unstructured": "Smedley, EH., Traube, M., Leach, R., and Wastell, C, Nonsteroidal anti-inflammatory drugs: retrospective study of 272 bleeding or perforated peptic ulcers. Postgrad. Med. J. 65: 892 (1989).", "journal-title": "Postgrad. Med. J"}, {"key": "4_CR25", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1136/bmj.290.6465.347", "volume": "290", "author": "MJS Langman", "year": "1985", "unstructured": "Langman, M.J.S., Morgan, L., and Worrall, A., Use of anti-inflammatory drugs by patients admitted with small and large bowel perforation and haemorrhage. Br. Med. J. 290: 347 (1985).", "journal-title": "Br. Med. J"}, {"key": "4_CR26", "first-page": "3", "volume": "3", "author": "WH Inman", "year": "1985", "unstructured": "Inman W.H., Comprehensive study of five non-steroidal anti-inflammatory drugs. Prescript. Event Monitor. News 3, 3 (1985).", "journal-title": "News"}, {"key": "4_CR27", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1001/archinte.1987.00370010087021", "volume": "147", "author": "JI Carson", "year": "1987", "unstructured": "Carson, J.I., Strom, B.L., Soper, K.A., West, S.I., and Morse, M.I., The association of non-steroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch. Intern. Med. 147: 85 (1987).", "journal-title": "Arch. Intern. Med"}, {"key": "4_CR28", "doi-asserted-by": "publisher", "first-page": "1621", "DOI": "10.1001/archinte.1987.00370090097017", "volume": "147", "author": "K Beard", "year": "1987", "unstructured": "Beard, K., Walker, A.M., Perera D.R., and Jick, H., Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch. Intern. Med. 147: 1621 (1987).", "journal-title": "Arch. Intern. Med"}, {"key": "4_CR29", "first-page": "497", "volume": "71", "author": "PHG Beardon", "year": "1989", "unstructured": "Beardon, P.H.G., Brown, S.V., and McDevitt, D.G., Gastro-intestinal events in patients prescribed non-steroidal anti-inflammatory drugs: A controlled study using record linkage in Tayside. Q. J. Med. 71: 497 (1989).", "journal-title": "Q. J. Med"}, {"key": "4_CR30", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1016/S0002-9343(86)80010-9", "volume": "81", "author": "EA Bortnichak", "year": "1986", "unstructured": "Bortnichak, E.A. and Sachs, R.M., Piroxicam in recent epidemiologic studies. Am. J. Med. 81: 44 (1986).", "journal-title": "Am. J. Med"}, {"key": "4_CR31", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1136/bmj.294.6565.147", "volume": "294", "author": "AC Rossi", "year": "1987", "unstructured": "Rossi, A.C., Hsu, J.P., and Faich, G.A., Ulcerogenicity of piroxicam. An analysis of spontaneously reported data. Br. Med. J. 294: 147 (1987).", "journal-title": "Br. Med. J"}, {"key": "4_CR32", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1136/bmj.3.5875.339", "volume": "3", "author": "LE Bottiger", "year": "1973", "unstructured": "Bottiger, L.E. and Westerholm, B., Blood-induced blood dyscrasias in Sweden. Br. Med. J. 3: 339 (1973).", "journal-title": "Br. Med. J"}, {"key": "4_CR33", "doi-asserted-by": "publisher", "first-page": "1500", "DOI": "10.1136/bmj.1.6075.1500", "volume": "1", "author": "WH Inman", "year": "1977", "unstructured": "Inman, W.H., Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br. Med. J. 1,1500 (1977).", "journal-title": "Br. Med. J"}, {"key": "4_CR34", "doi-asserted-by": "publisher", "first-page": "833", "DOI": "10.1007/BF00607096", "volume": "24", "author": "International Agranulocytosis and Aplastic Anemia Study", "year": "1983", "unstructured": "International Agranulocytosis and Aplastic Anemia Study, The design of a study of the drug etiology of agranulocytosis and aplastic anemia. Eur. J. Clin. Pharmacol. 24: 833 (1983).", "journal-title": "Eur. J. Clin. Pharmacol"}, {"key": "4_CR35", "doi-asserted-by": "publisher", "first-page": "1749", "DOI": "10.1001/jama.1986.03380130077032", "volume": "256", "author": "International Agranulocytosis and Aplastic Anemia Study", "year": "1986", "unstructured": "International Agranulocytosis and Aplastic Anemia Study, Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. J. Am. Med. Assn. 256: 1749 (1986).", "journal-title": "J. Am. Med. Assn."}, {"key": "4_CR36", "first-page": "859", "volume": "66", "author": "KM Starko", "year": "1980", "unstructured": "Starko, K. M., Ray, C. G., and Dominguez, L. B., Reye\u2019s syndrome and salicylate use. Pediatrics 66: 859 (1980).", "journal-title": "Pediatrics"}], "container-title": ["Adverse Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Pharmacoepidemiology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-0348-5722-2_4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T13:13:46Z", "timestamp": 1558012426000}, "score": 42.17381, "issued": {"date-parts": [[1992]]}, "ISBN": ["9783034857246", "9783034857222"], "references-count": 36, "URL": "http://dx.doi.org/10.1007/978-3-0348-5722-2_4", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:17:28Z", "timestamp": 1574320648056}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 9, 1]], "date-time": "2009-09-01T00:00:00Z", "timestamp": 1251763200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2009, 9]]}, "DOI": "10.1016/s1359-6349(09)70919-x", "type": "journal-article", "created": {"date-parts": [[2009, 9, 3]], "date-time": "2009-09-03T12:23:03Z", "timestamp": 1251980583000}, "page": "269", "source": "Crossref", "is-referenced-by-count": 1, "title": ["5027 A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC)"], "prefix": "10.1016", "volume": "7", "author": [{"given": "O.", "family": "Freedman", "sequence": "first", "affiliation": []}, {"given": "E.", "family": "Amir", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Dranitsaris", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Dowsett", "sequence": "additional", "affiliation": []}, {"given": "D.E.C.", "family": "Cole", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Hanna", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "O'Malley", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Folkerd", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Verma", "sequence": "additional", "affiliation": []}, {"given": "M.J.", "family": "Clemons", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S135963490970919X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S135963490970919X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 17]], "date-time": "2018-12-17T11:26:25Z", "timestamp": 1545045985000}, "score": 42.118504, "issued": {"date-parts": [[2009, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 9]]}, "issue": "2"}, "alternative-id": ["S135963490970919X"], "URL": "http://dx.doi.org/10.1016/s1359-6349(09)70919-x", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:00:23Z", "timestamp": 1574524823091}, "publisher-location": "Basel", "reference-count": 19, "publisher": "Birkh\u00e4user Basel", "isbn-type": [{"value": "9783764317508", "type": "print"}, {"value": "9783034877206", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1985]]}, "DOI": "10.1007/978-3-0348-7720-6_18", "type": "book-chapter", "created": {"date-parts": [[2012, 12, 30]], "date-time": "2012-12-30T07:21:21Z", "timestamp": 1356852081000}, "page": "151-155", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Relationship between the Plasma Concentration of Non-Steroidal Anti-Inflammatory Drugs and Their Therapeutic Effects"], "prefix": "10.1007", "author": [{"given": "M. L\u2019E.", "family": "Orme", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "18_CR1", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.2165/00003495-197917060-00005", "volume": "17", "author": "A Richens", "year": "1979", "unstructured": "Richens A, Warrington SJ (1979) Drugs 17: 488\u2013500", "journal-title": "Drugs"}, {"key": "18_CR2", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.2165/00003088-197803010-00003", "volume": "3", "author": "M Danhof", "year": "1978", "unstructured": "Danhof M, Breimer DD (1978) Clin. Pharmacokin 3: 39\u201357", "journal-title": "Clin. Pharmacokin"}, {"key": "18_CR3", "doi-asserted-by": "publisher", "first-page": "466", "DOI": "10.1016/0002-9343(77)90398-9", "volume": "62", "author": "M Reidenberg", "year": "1978", "unstructured": "Reidenberg M (1978) Am. J. Med. 62: 466\u2013470", "journal-title": "Am. J. Med"}, {"key": "18_CR4", "author": "M Orme", "first-page": "3", "year": "1976", "unstructured": "Orme M, Holt PJL, Hughes GRV et al (1976) Brit. J. Clin. Pharmac 3: 185\u2013191", "volume-title": "Brit. J"}, {"key": "18_CR5", "author": "RO Day", "first-page": "31", "year": "1982", "unstructured": "Day RO, Furst DE, Dromgoole SH et al (1982) Clin. Pharmac. Ther. 31: 733\u2013740", "volume-title": "Clin"}, {"key": "18_CR6", "author": "HW Emori", "first-page": "32", "year": "1973", "unstructured": "Emori HW, Champion DG, Bluestone R et al (1973) Ann. Rheum. Dis. 32: 433\u2013435", "volume-title": "Ann"}, {"key": "18_CR7", "author": "TM Chalmers", "first-page": "9", "year": "1980", "unstructured": "Chalmers TM, Glass RC, Marchant B (1980) Br. J. Clin. Pract. Suppl 9, 3\u20135", "volume-title": "Br. J. Clin"}, {"key": "18_CR8", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.2165/00003088-198005050-00002", "volume": "5", "author": "M Mandelli", "year": "1980", "unstructured": "Mandelli M, Tognoni G (1980) Clin. Pharmacokin 5: 424\u2013440", "journal-title": "Clin. Pharmacokin"}, {"key": "18_CR9", "first-page": "457", "volume": "11", "author": "P Tugwell", "year": "1984", "unstructured": "Tugwell P, Hart L, Kraag G et al (1984) J. Rheumatol. 11: 457\u2013461", "journal-title": "J. Rheumatol"}, {"key": "18_CR10", "author": "M Bardare", "first-page": "53", "year": "1978", "unstructured": "Bardare M, Chislaghi GU, Mandelli M et al (1978) Arch. Dis. Child. 53, 381\u2013385", "volume-title": "Arch"}, {"key": "18_CR11", "author": "PM Brooks", "first-page": "2", "year": "1975", "unstructured": "Brooks PM, Walker JJ, Dick WC et al (1975) Brit. J. Clin. Pharmac. 2: 437\u2013442", "volume-title": "Brit. J"}, {"key": "18_CR12", "author": "Orme ML\u2019E, Holt PJL", "first-page": "3", "year": "1976", "unstructured": "Orme ML\u2019E, Holt PJL, Hughes GRV et al (1976) Brit. J. Clin. Pharmac. 3: 185\u2013191", "volume-title": "Brit. J"}, {"key": "18_CR13", "author": "HA Bird", "first-page": "40", "year": "1981", "unstructured": "Bird HA, Lowe JR, Leatham PA et al (1981) Ann. Rheum. Dis. 40: 621\u2013622", "volume-title": "Ann"}, {"key": "18_CR14", "author": "A Rane", "first-page": "23", "year": "1978", "unstructured": "Rane A, Oelz 0, Frblich J et al (1978) Clin. Pharmac. Ther. 23: 658\u2013668", "volume-title": "Clin"}, {"key": "18_CR15", "author": "Orme ML\u2019E, Baber NS", "first-page": "9", "year": "1980", "unstructured": "Orme ML\u2019E, Baber NS, Halliday L et al (1980) Brit. J. Clin. Pract. Suppl 9 36\u201342", "volume-title": "Brit. J. Clin"}, {"key": "18_CR16", "doi-asserted-by": "publisher", "first-page": "167", "DOI": "10.1016/0163-7258(82)90052-3", "volume": "16", "author": "Orme ML\u2019E", "year": "1982", "unstructured": "Orme ML\u2019E (1982) Pharmac. Ther. 16: 167\u2013180", "journal-title": "Pharmac. Ther"}, {"key": "18_CR17", "author": "G Tomson", "first-page": "29", "year": "1980", "unstructured": "Tomson G, Lunell NO, Oliw E et al (1980) Clin. Pharmac. Ther. 29: 168\u2013173", "volume-title": "Clin"}, {"key": "18_CR18", "unstructured": "Dunagan FM, Kelman AW, McGill PE et al (1985) Brit. J. Clin. Pharmac (in press)"}, {"key": "18_CR19", "author": "W Siegmeth", "first-page": "31", "year": "1980", "unstructured": "Siegmeth W (1980) Wein. med. Wschr. Special issue 31\u201335.", "volume-title": "Wein. med"}], "container-title": ["Non-steroidal Anti-Inflammatory Drugs Basis for Variability in Response"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-0348-7720-6_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 10]], "date-time": "2019-05-10T03:15:00Z", "timestamp": 1557458100000}, "score": 41.881195, "issued": {"date-parts": [[1985]]}, "ISBN": ["9783764317508", "9783034877206"], "references-count": 19, "URL": "http://dx.doi.org/10.1007/978-3-0348-7720-6_18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T04:19:22Z", "timestamp": 1575260362260}, "publisher-location": "Basel", "reference-count": 69, "publisher": "Birkh\u00e4user Basel", "isbn-type": [{"value": "9783034857246", "type": "print"}, {"value": "9783034857222", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1992]]}, "DOI": "10.1007/978-3-0348-5722-2_9", "type": "book-chapter", "created": {"date-parts": [[2013, 8, 7]], "date-time": "2013-08-07T08:34:44Z", "timestamp": 1375864484000}, "page": "91-103", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Kidney Function Impairment: Do Relevant Differences between Non-Steroidal Anti-Inflammatory Drugs Exist?"], "prefix": "10.1007", "author": [{"given": "J.", "family": "Mann", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Goerig", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "9_CR1", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1096/fasebj.1.2.3111928", "volume": "1", "author": "J Vane", "year": "1987", "unstructured": "Vane, J. and Botting, R., Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J. 1: 89\u201396 (1987).", "journal-title": "FASEB J"}, {"key": "9_CR2", "doi-asserted-by": "publisher", "first-page": "563", "DOI": "10.1056/NEJM198403013100905", "volume": "310", "author": "DM Clive", "year": "1984", "unstructured": "Clive, D.M. and Stoff, J.S., Renal syndromes associated with non-steroidal anti-inflammatory drugs. N. Engl. J. Med. 310: 563\u2013572 (1984).", "journal-title": "N. Engl. J. Med."}, {"key": "9_CR3", "author": "EC Huskisson", "first-page": "1", "year": "1983", "unstructured": "Huskisson, E.C,. Classification of anti-rheumatic drugs. In: Huskisson, E.C. (Ed.), Antirheumatic drugs. Praeger Publishers, New York 1983, pp. 1\u20139.", "volume-title": "Antirheumatic drugs"}, {"key": "9_CR4", "first-page": "105", "volume": "1", "author": "GA Higgs", "year": "1976", "unstructured": "Higgs, G.A., Harvey, E.A., Ferreira, S.H., and Vane, J.R., The effects of antiinflammatory drugs on the production of prostaglandins in vivo. Adv. Prostaglandin Thromboxane Leukotriene Res. 1: 105\u2013110 (1976).", "journal-title": "Adv. Prostaglandin Thromboxane Leukotriene Res"}, {"key": "9_CR5", "first-page": "12572", "volume": "260", "author": "RJ Kulmacz", "year": "1985", "unstructured": "Kulmacz, R.J. and Lands, W.E.M., Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J. Biol. Chem. 260: 12572\u201312578 (1985).", "journal-title": "J. Biol. Chem"}, {"key": "9_CR6", "unstructured": "Halliwell, B., Hoult, J.R., and Blake, D.R., Oxidants, inflammation, and antiinflammatory drugs. FASEB J. 2: 2867\u20132873.", "DOI": "10.1096/fasebj.2.13.2844616", "doi-asserted-by": "crossref"}, {"key": "9_CR7", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1007/BF00914026", "volume": "14", "author": "SB Abrahamson", "year": "1990", "unstructured": "Abrahamson, S.B., Chersky, B., Gude, D., et al. Non-steroidal anti-inflammatory drugs exert differential effects on neutrophil function and plasma membrane viscosity. Inflammation 14:11\u201329(1990).", "journal-title": "Inflammation"}, {"key": "9_CR8", "first-page": "2151", "volume": "45", "author": "EL Becker", "year": "1986", "unstructured": "Becker, E.L., Kermode, J.C., Naccache, RH. et al. Pertussis toxin as a probe of neutrophil activation. Fed. Proc. 45: 2151\u20132155 (1986).", "journal-title": "Fed. Proc"}, {"key": "9_CR9", "first-page": "1389", "volume": "46", "author": "S Abrahamson", "year": "1987", "unstructured": "Abrahamson, S., Cherksky, B., Veiro, D. et al., Nonsteroidal antiinflammatory agents, but not acetaminophen, disrupt signal transduction within the neutrophil plasmalemma. Fed. Proc. 46: 1389(1987).", "journal-title": "Fed. Proc"}, {"key": "9_CR10", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1007/BF00917455", "volume": "14", "author": "RE Crowell", "year": "1990", "unstructured": "Crowell, R.E. and Vaan Epps, D.E., Non-steroidal anti-inflammatory agents inhibt upregu-lation of CDllb, CDllc, and CD35 in neutrophils stimulated by formyl-methionine-leucine-phenylalanine. Inflammation 14: 163\u2013171 (1990).", "journal-title": "Inflammation"}, {"key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "400", "DOI": "10.1172/JCI114725", "volume": "86", "author": "RA Levine", "year": "1990", "unstructured": "Levine, R.A., Nandi, J., and King, R.L., Aspirin potentiates prestimulated acid secretion and mobilizes intracellular calcium in rabbit parietal cells. J. Clin. Invest. 86: 400\u2013408 (1990).", "journal-title": "J. Clin. Invest."}, {"key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1038/ki.1987.164", "volume": "32", "author": "C Patrono", "year": "1987", "unstructured": "Patrono, C. and Dunn, M.J., The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int. 32: 1\u201312 (1987).", "journal-title": "Kidney Int."}, {"key": "9_CR13", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1146/annurev.bi.55.070186.000441", "volume": "55", "author": "P Needleman", "year": "1986", "unstructured": "Needleman, P., Turk, J., Jakschik, A. et al., Arachidonic acid metabolism. Annu. Rev. Biochem. 55: 69\u2013102 (1986).", "journal-title": "Annu. Rev. Biochem."}, {"key": "9_CR14", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1172/JCI114714", "volume": "86", "author": "DG Gardner", "year": "1990", "unstructured": "Gardner, D.G. and Schultz, H.D., Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide. J. Clin. Invest. 86: 52\u201359 (1990).", "journal-title": "J. Clin. Invest."}, {"key": "9_CR15", "first-page": "3510", "volume": "262", "author": "PJ Marshall", "year": "1987", "unstructured": "Marshall, P. J., Kulmacz, R.J., and Lands, W.E.M., Constraints on prostaglandin biosynthesis in tissues. J. Biol. Chem. 262: 3510\u20135317 (1987).", "journal-title": "J. Biol. Chem"}, {"key": "9_CR16", "doi-asserted-by": "publisher", "first-page": "761", "DOI": "10.1056/NEJM198809223191206", "volume": "319", "author": "JA Oates", "year": "1988", "unstructured": "Oates, J.A., FitzGerald, G.A., Branch, R.A. et al., Clinical implications of prostaglandin and thromboxane A2 formation. N. Engl. J. Med. 319: 761\u2013767 (1988).", "journal-title": "N. Engl. J. Med."}, {"key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1055/s-2008-1065008", "volume": "115", "author": "GP Oberle", "year": "1990", "unstructured": "Oberle, G.P. and Stahl, R.A.K., Akute Nebenwirkungen nicht-steroidaler Antiphlogistika auf die Nieren. Dtsch. Med. Wochenschr. 115: 309\u2013314 (1990).", "journal-title": "Dtsch. Med. Wochenschr"}, {"key": "9_CR18", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1055/s-2008-1068040", "volume": "112", "author": "L Koeppen-Hagemann", "year": "1987", "unstructured": "Koeppen-Hagemann, L, Binkele-Uihlein, U., Waldherr, R., Andrassy, K. et al., Akute granulomat\u00f6se interstitielle Nephritis mit Iritis. Dtsch. Med. Wochenschr. 112: 259\u2013261 (1987).", "journal-title": "Dtsch. Med. Wochenschr."}, {"key": "9_CR19", "doi-asserted-by": "publisher", "first-page": "1238", "DOI": "10.1056/NEJM198905113201903", "volume": "320", "author": "DP Sandler", "year": "1989", "unstructured": "Sandler, D.P., Smith, J.C., Weinberg, CR. et al., Analgesic use and chronic renal disease. N. Engl. J. Med. 320: 1238\u20131242 (1989).", "journal-title": "N. Engl. J. Med."}, {"key": "9_CR20", "doi-asserted-by": "publisher", "first-page": "1269", "DOI": "10.1056/NEJM198905113201908", "volume": "320", "author": "WM Bennett", "year": "1989", "unstructured": "Bennett, WM. and DeBroe, M.E., Analgesie nephropathy-a preventable renal disease. N. Engl. J. Med. 320: 1269\u20131271 (1989).", "journal-title": "N. Engl. J. Med."}, {"key": "9_CR21", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1016/S0140-6736(86)90714-2", "volume": "1", "author": "DH Adams", "year": "1986", "unstructured": "Adams, D.H., Howie, A.J., Michael, J., McConkey, B. et al. Nonsteroidal antiinflammatory drugs and renal failure. Lancet 1:57\u201360 (1986).", "journal-title": "Lancet"}, {"key": "9_CR22", "doi-asserted-by": "publisher", "first-page": "2732", "DOI": "10.1001/jama.1979.03290510040025", "volume": "241", "author": "SY Tan", "year": "1979", "unstructured": "Tan, S.Y., Shapiro, R., and Ksih, M.A., Reversible acute renal failure induced by indo-methacin. J. Am. Med. Assn. 241: 2732\u20132733 (1979).", "journal-title": "J. Am. Med. Assn."}, {"key": "9_CR23", "first-page": "490", "volume": "234", "author": "D Feldman", "year": "1978", "unstructured": "Feldman, D., Loose, D.S., and Tan, S.Y., Nonsteroidal antiinflammatorv drugs cause sodium and water retention in the rat. Am. J. Physiol. 234: F490\u2013F4966 (1978).", "journal-title": "Am. J. Physiol."}, {"key": "9_CR24", "doi-asserted-by": "crossref", "first-page": "322", "DOI": "10.1002/cpt1979253322", "volume": "25", "author": "DC Brater", "year": "1979", "unstructured": "Brater, D.C., Effects of indomethacin on salt and water homeostasis. Clin. Pharmacol. Then 25: 322\u2013330 (1979).", "journal-title": "Clin. Pharmacol. Then"}, {"key": "9_CR25", "doi-asserted-by": "publisher", "first-page": "649", "DOI": "10.1016/S0090-6980(75)80012-8", "volume": "10", "author": "RV Patak", "year": "1975", "unstructured": "Patak, R.V., Mookerjee, B.K., Bentzel, C.J., Hysert, P.E. et al., Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10: 649\u2013659 (1975).", "journal-title": "Prostaglandins"}, {"key": "9_CR26", "doi-asserted-by": "publisher", "first-page": "559", "DOI": "10.7326/0003-4819-112-8-559", "volume": "112", "author": "MD Murray", "year": "1990", "unstructured": "Murray, M.D. and Brater, D.C., Adverse effects of non-steroidal antiinflammatory drugs on renal function. Ann. Intern. Med. 112: 559\u2013560 (1990).", "journal-title": "Ann. Intern. Med."}, {"key": "9_CR27", "first-page": "1916", "volume": "87", "author": "M Kurowski", "year": "1990", "unstructured": "Kurowski, M., SPALA \u2014 Sicherheitsprofil von Antirheumatika bei Langzeitanwendung. Dtsch. \u00c4rzteblatt 87: 1916\u20131924 (1990).", "journal-title": "Dtsch. \u00c4rzteblatt"}, {"key": "9_CR28", "doi-asserted-by": "publisher", "first-page": "1299", "DOI": "10.1001/jama.1984.03340340039023", "volume": "251", "author": "DA Fox", "year": "1984", "unstructured": "Fox, D.A. and Jick, H., Non-steroidal anti-inflammatory drugs and renal disease. J. Am. Med. Assn. 251: 1299\u20131300 (1984).", "journal-title": "J. Am. Med. Assn."}, {"key": "9_CR29", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1038/clpt.1986.193", "volume": "40", "author": "SL Bonney", "year": "1986", "unstructured": "Bonney, S.L., Northington, R.S., Hedrich, D.A., and Walker, B.R., Renal safety of two analgesics used over the counter: ibuprofen and aspirin. Clin. Pharmacol. Ther. 40:373\u2013377 (1986).", "journal-title": "Clin. Pharmacol. Ther."}, {"key": "9_CR30", "doi-asserted-by": "publisher", "first-page": "271", "DOI": "10.1038/284271a0", "volume": "284", "author": "BJR Whittle", "year": "1980", "unstructured": "Whittle, B.J.R., Higgs, G.A., Eakins, K.E. et al., Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271\u2013273 (1980).", "journal-title": "Nature"}, {"key": "9_CR31", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1016/0014-2999(80)90297-6", "volume": "66", "author": "GA Higgs", "year": "1980", "unstructured": "Higgs, G.A., Eakins, K.E., Mugridge, K.G., et al., The effects of nonsteroid antiinflammtory drugs on leukocyte migration in carrageen-induced inflammation. Eur. J. Pharmacol. 66: 81\u201386(1980).", "journal-title": "Eur. J. Pharmacol."}, {"key": "9_CR32", "doi-asserted-by": "publisher", "first-page": "11", "DOI": "10.1185/03007997709108969", "volume": "5", "author": "SS Adams", "year": "1977", "unstructured": "Adams, S.S., Burrows, C.A., Sheldon, N., and Yates, D.B., Inhibition of prostaglandin synthesis and leukocyte migration by flurbiprofen. Curr. Med. Res. 5: 11\u201316 (1977).", "journal-title": "Curr. Med. Res"}, {"key": "9_CR33", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1111/j.2042-7158.1980.tb12874.x", "volume": "32", "author": "PC Bragt", "year": "1980", "unstructured": "Bragt, P.C. and Bonta, I.L., Indomethacin inhibits the formation of the lipoxygenase product HETE during granulomatous inflammation in the rat. J. Pharm. Pharmacol. 32: 143\u2013144 (1980).", "journal-title": "J. Pharm. Pharmacol"}, {"key": "9_CR34", "doi-asserted-by": "publisher", "first-page": "1781", "DOI": "10.1016/0006-2952(81)90010-1", "volume": "30", "author": "Y Koshihara", "year": "1981", "unstructured": "Koshihara, Y., Nagasaki, I., and Murota, S.I., Production of slow reacting substance in rat granulomatous inflammation. Biochem. Pharmacol. 30: 1781\u20131784 (1981).", "journal-title": "Biochem. Pharmacol"}, {"key": "9_CR35", "doi-asserted-by": "publisher", "first-page": "553", "DOI": "10.1007/BF02024164", "volume": "10", "author": "RW Randall", "year": "1980", "unstructured": "Randall, R.W., Eakins, K.E., Higgs, G.A. et al. Inhibition of arachidonic acid cyclo-oxy-genase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C. Agents Actions 10: 553\u2013555 (1980).", "journal-title": "Agents Actions"}, {"key": "9_CR36", "author": "AR Rhymer", "first-page": "421", "year": "1983", "unstructured": "Rhymer, A.R., Sulindac. In: Huskisson, E.C. (Ed.), Anti-rheumatic drugs. Praeger Publishers, New York 1983, pp. 421\u20134437.", "volume-title": "Anti-rheumatic drugs"}, {"key": "9_CR37", "first-page": "9", "volume": "1", "author": "KC Kwan", "year": "1978", "unstructured": "Kwan, K.C., Duggan, D.E., Van Annan, E.G., and Shen, T.Y,. Sulindac: chemistry, pharmacology and pharmacokinetics. Eur. J. Rheumatol. Inflamm. 1: 9\u201311 (1978).", "journal-title": "Eur. J. Rheumatol. Inflamm"}, {"key": "9_CR38", "first-page": "210", "volume": "3", "author": "G Ciabattoni", "year": "1980", "unstructured": "Ciabattoni, G., Pugliese, F., Cinotti, G. A., and Patrono, C, Renal effects of antiinflammatory drugs. Eur. J. Rheumatol., 3: 210\u2013212 (1980).", "journal-title": "Eur. J. Rheumatol."}, {"key": "9_CR39", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1056/NEJM198402023100502", "volume": "310", "author": "G Ciabattoni", "year": "1984", "unstructured": "Ciabattoni, G., Cinotti, G.A., Pierucci, A. et al., Effects of sulindac and ibuprofen inpatients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N. Engl. J. Med. 310: 279\u2013283 (1984).", "journal-title": "N. Engl. J. Med."}, {"key": "9_CR40", "doi-asserted-by": "publisher", "first-page": "568", "DOI": "10.7326/0003-4819-112-8-568", "volume": "112", "author": "A Whelton", "year": "1990", "unstructured": "Whelton, A., Stout, R.L., Spilman, P.S., and Klassen, D.K., Renal effects of ibuprofen, Piroxicam, and sulindac in patients with asymtomatic renal failure. A prospective, randomized, crossover comparison. Ann. Intern. Med. 112: 568\u2013576 (1990).", "journal-title": "Ann. Intern. Med."}, {"key": "9_CR41", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1159/000183692", "volume": "42", "author": "E Quintero", "year": "1986", "unstructured": "Quintero, E., Gines, P., Arroyo, V., Rimola, A. et al., Sulindac reduces the urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron 42: 298\u2013303 (1986).", "journal-title": "Nephron"}, {"key": "9_CR42", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1016/0016-5085(86)90921-2", "volume": "90", "author": "G Laffi", "year": "1986", "unstructured": "Laffi, G., La Villa, G., Pinzani, M., Ciabattoni, G. et al., Altered and renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology 90: 274\u2013282 (1986).", "journal-title": "Gastroenterology"}, {"key": "9_CR43", "doi-asserted-by": "publisher", "first-page": "456", "DOI": "10.1038/278456a0", "volume": "278", "author": "RJ Flower", "year": "1979", "unstructured": "Flower, R.J. and Blackwell, G.J., Antiinflammatory steroids induce biosynthesis of a phospholipase inhibitor which prevents prostaglandin generation. Nature 278: 456\u2013459 (1979).", "journal-title": "Nature"}, {"key": "9_CR44", "first-page": "89", "volume": "38", "author": "JC McGiff", "year": "1979", "unstructured": "McGiff, J.C. and Wong, P.Y., Compartmentalization of prostaglandins and prostacyclin within the kidney: implications for renal function. Fed. Proc. 38: 89\u201393 (1979).", "journal-title": "Fed. Proc"}, {"key": "9_CR45", "doi-asserted-by": "publisher", "first-page": "258", "DOI": "10.1038/clpt.1985.168", "volume": "38", "author": "DG Roberts", "year": "1985", "unstructured": "Roberts, D.G., Gerber, J.G., Barnes, J.S., Zebre, G.O. et al., Sulindac is not renal-sparing in man. Clin. Pharmacol. Ther. 38: 258\u2013265 (1985).", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "9_CR46", "first-page": "131", "volume": "2", "author": "DL Ebel", "year": "1985", "unstructured": "Ebel, D.L., Rhymer, A.R., and Stahl, E., Effects of sulindac, piroxicam and placebo on the hypotensive effect of propranolol in patients with mild to moderate essential hypertension. Adv. Ther. 2: 131\u2013142 (1985).", "journal-title": "Adv. Ther."}, {"key": "9_CR47", "doi-asserted-by": "publisher", "first-page": "1492", "DOI": "10.1136/bmj.289.6457.1492", "volume": "289", "author": "PP Koopmans", "year": "1984", "unstructured": "Koopmans, P.P., Thien, T.H., and Gribnau, F.W.J., Influence of nonsteroidal antiin-flammtory drugs on diuretic treatment of mild to moderate essential hypertension. Br. Med. J. 289: 1492\u20131494 (1984).", "journal-title": "Br. Med. J"}, {"key": "9_CR48", "doi-asserted-by": "publisher", "first-page": "934", "DOI": "10.1136/bmj.292.6525.934-a", "volume": "292", "author": "RV Lewis", "year": "1986", "unstructured": "Lewis, R.V., Toner, J.M., Jackson, P.R., and Ramsay L.E., Effects of indomethacin and sulindac on blood pressure of hypertensive patients. Br. Med. J. 292: 934\u2013935 (1986).", "journal-title": "Br. Med. J"}, {"key": "9_CR49", "doi-asserted-by": "publisher", "first-page": "478", "DOI": "10.1111/j.1445-5994.1982.tb03826.x", "volume": "12", "author": "EH Mills", "year": "1982", "unstructured": "Mills, E.H., Whitworth, J.A., Andrews, J., and Kincaid-Smith, P., Nonsteroidal antiinflammatory drugs and blood pressure. Aust. N. Z. J. Med. 12: 478\u2013482 (1982).", "journal-title": "Aust. N. Z. J. Med."}, {"key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1042/cs0690327", "volume": "69", "author": "LB Puddey", "year": "1985", "unstructured": "Puddey, LB., Beilin, L.J., Vandongen, R., Banks, R. et al., Differential effects of sulindac and indomethacin on blood pressure in treated essential hypertensive subjects. Clin. Sci. 69: 327\u2013336 (1985).", "journal-title": "Clin. Sci."}, {"key": "9_CR51", "doi-asserted-by": "publisher", "first-page": "1702", "DOI": "10.1136/bmj.285.6356.1702-a", "volume": "285", "author": "E Steiness", "year": "1982", "unstructured": "Steiness, E. and Waldorff, S., Different interaction of indomethacin and sulindac with thiazides in hypertension. Br. Med. J. 285: 1702\u20131703 (1982).", "journal-title": "Br. Med. J"}, {"key": "9_CR52", "doi-asserted-by": "publisher", "first-page": "997", "DOI": "10.1016/S0140-6736(86)91271-7", "volume": "i", "author": "DG Wong", "year": "1986", "unstructured": "Wong, D.G., Spence, J.D., Lamki, L., Freeman, D. et al., Effect of nonsteroidal antiinflammatory drugs on control of hypertension by beta blockers and diuretics. Lancet i:997\u20131001 (1986).", "journal-title": "Lancet"}, {"key": "9_CR53", "first-page": "105", "volume": "25", "author": "R Vriesendorp", "year": "1986", "unstructured": "Vriesendorp, R., De Zweeuw, D., De Jong, P.E., Donker, A.J.M. et al., Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by nonsteroidal antiinflammatory drugs. Clin. Nephrol. 25: 105\u2013110 (1986).", "journal-title": "Clin. Nephrol"}, {"key": "9_CR54", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.3109/03009748609101451", "volume": "62", "author": "AL Kamper", "year": "1986", "unstructured": "Kamper, A.L., Strandgaard, S., Christensen, P., and Svendsen, U.G., Effects of sulindac and naproxen in patients with chronic glomerular disease. Scand. J. Rheumatol. 62 (Suppl): 26 (1986).", "journal-title": "Scand. J. Rheumatol"}, {"key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/S0272-6386(85)80176-1", "volume": "6", "author": "G Daskalopoulos", "year": "1985", "unstructured": "Daskalopoulos, G., Kronborg, I., Katkov, W, Gonzales, M. et al., Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. Am. J. Kidney Dis. 6: 217\u2013221 (1985).", "journal-title": "Am. J. Kidney Dis"}, {"key": "9_CR56", "doi-asserted-by": "publisher", "first-page": "231", "DOI": "10.3109/00365528609034652", "volume": "21", "author": "C Guarner", "year": "1986", "unstructured": "Guarner, C, Enriquez, F Guarner et al. Effects of sulindac on prostaglandin excretion and renal function in cirrhotic patients with ascites. Scand. J. Gastroenterol. 21:231\u2013234 (1986).", "journal-title": "Scand. J. Gastroenterol"}, {"key": "9_CR57", "doi-asserted-by": "publisher", "first-page": "646", "DOI": "10.1038/clpt.1987.213", "volume": "42", "author": "LO Eriksson", "year": "1987", "unstructured": "Eriksson, L.O., Beermann, B., and Kallner, M., Renal function and tubular transport effects of sulindac and naproxen in chronic heart failure. Clin. Pharmacol. Ther. 42: 646\u2013654 (1987).", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "9_CR58", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.3109/03009748609101452", "volume": "62", "author": "B Beermann", "year": "1986", "unstructured": "Beermann, B., Eriksson, L.O., and Kallner, M., A double blind comparison of naproxen and sulindac in female patients with heart failure. Scand. J. Rheumatol. 62: 32 (1986).", "journal-title": "Scand. J. Rheumatol"}, {"key": "9_CR59", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1016/0002-9343(86)90908-3", "volume": "81", "author": "JR Sedor", "year": "1986", "unstructured": "Sedor, J.R., Davidson, E., and Dunn, M.J., Effects of nonsteroidal antiinflammatory drugs in healthy subjects. Am. J. Med. 81: 58\u201370 (1986).", "journal-title": "Am. J. Med."}, {"key": "9_CR60", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1042/cs0700501", "volume": "70", "author": "CD Mistry", "year": "1986", "unstructured": "Mistry, C.D., Lote, C.J., Gokal, R., Currie, W.J. et al., Effects of sulindac on renal function and prostaglandin synthesis in patients with moderate chronic renal insufficiency. Clin. Sci. 70: 501\u2013505 (1986).", "journal-title": "Clin. Sci."}, {"key": "9_CR61", "doi-asserted-by": "publisher", "first-page": "1131", "DOI": "10.1001/archinte.1983.00350060052007", "volume": "143", "author": "JL Blackshear", "year": "1983", "unstructured": "Blackshear, J.L., Davidman, M., and Stillmann, T., Identification of risk for renal insufficiency from non-steroidal anti-inflammatory drugs. Arch. Intern. Med. 143: 1131 (1983).", "journal-title": "Arch. Intern. Med."}, {"key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1016/S0272-6386(84)80063-3", "volume": "4", "author": "HK Corwin", "year": "1984", "unstructured": "Corwin, H.K. and Bonventre, J.V., Renal insufficiency associated with nonsteroidal antiinflammatory agents. Am. J. Kidney Dis. 4: 147 (1984).", "journal-title": "Am. J. Kidney Dis"}, {"key": "9_CR63", "first-page": "560", "volume": "228", "author": "EJ Zambraski", "year": "1984", "unstructured": "Zambraski, E.J., Chremos, A.N., and Dunn, M.J., Comparison of the effects of sulindac with other cyclooxygenase inhihitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swine. J. Pharmacol. Exp. Ther. 228:560\u2013566 (1984).", "journal-title": "J. Pharmacol. Exp. Ther"}, {"key": "9_CR64", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1042/cs063261s", "volume": "63", "author": "A Salvetti", "year": "1982", "unstructured": "Salvetti, A., Pedrinelli, R., Magagna, A. and Ugenti, P., Differential effects of selective and non-selective prostaglandin synthesis inhibition on the pharmacology responses to Captopril in patients with essential hypertension. Clin. Sci. 63: 261S-263S (1982).", "journal-title": "Clin. Sci."}, {"key": "9_CR65", "doi-asserted-by": "publisher", "first-page": "108", "DOI": "10.1111/j.1365-2125.1984.tb02442.x", "volume": "17", "author": "A Salvetti", "year": "1984", "unstructured": "Salvetti, A., Pedrinelli, R., Alberici, P., Magagna, A. et al. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. Br. J. Clin. Pharmacol. 17: 108S-111S (1984).", "journal-title": "Br. J. Clin. Pharmacol"}, {"key": "9_CR66", "doi-asserted-by": "publisher", "first-page": "380", "DOI": "10.1038/clpt.1987.44", "volume": "41", "author": "G Ciabattoni", "year": "1987", "unstructured": "Ciabattoni, G., Boss, A.H., Patrignani, P., Catella, F. et al. Dose-dependent inhibition of extra-renal prostacyclin production by sulindac in man. Clin. Pharmacol. Ther. 41:380\u2013383 (1987).", "journal-title": "Clin. Pharmacol. Ther"}, {"key": "9_CR67", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1097/00000441-198709000-00007", "volume": "294", "author": "DC Brater", "year": "1987", "unstructured": "Brater, D.C., Anderson, S.A., and Brown-Cartwright, D., Reversible acute decrease in renal function by NSAIDs in cirrhosis. Am. J. Med. Sci. 294: 168\u2013174 (1987).", "journal-title": "Am. J. Med. Sci."}, {"key": "9_CR68", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1038/ki.1986.25", "volume": "29", "author": "WL Henrich", "year": "1986", "unstructured": "Henrich, W.L., Brater, D.C., and Campell, W.B., Renal hemodynamic effects of therapeutic plasma levels of sulindac sulfide during hemorrhage. Kidney Int. 29: 484\u2013489 (1986).", "journal-title": "Kidney Int"}, {"key": "9_CR69", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1038/ki.1985.11", "volume": "27", "author": "DC Brater", "year": "1985", "unstructured": "Brater, D.C., Anderson, S., Baird, B., and Campbell, W.B., Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int. 27: 66\u201373 (1985).", "journal-title": "Kidney Int"}], "container-title": ["Adverse Reactions to Non-Steroidal Anti-Inflammatory Drugs: Clinical Pharmacoepidemiology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-0348-5722-2_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 16]], "date-time": "2019-05-16T12:57:11Z", "timestamp": 1558011431000}, "score": 41.881195, "issued": {"date-parts": [[1992]]}, "ISBN": ["9783034857246", "9783034857222"], "references-count": 69, "URL": "http://dx.doi.org/10.1007/978-3-0348-5722-2_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T19:59:15Z", "timestamp": 1574539155781}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 12, 15]]}, "DOI": "10.1158/0008-5472.sabcs12-p2-14-01", "type": "proceedings-article", "created": {"date-parts": [[2014, 8, 14]], "date-time": "2014-08-14T22:35:55Z", "timestamp": 1408055755000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract P2-14-01: Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors \u2013 a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007)"], "prefix": "10.1158", "author": [{"given": "SRD", "family": "Johnston", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Chia", "sequence": "additional", "affiliation": []}, {"given": "LS", "family": "Kilburn", "sequence": "additional", "affiliation": []}, {"given": "WJ", "family": "Gradishar", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Cameron", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Dodwell", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Howell", "sequence": "additional", "affiliation": []}, {"given": "Y-H", "family": "Im", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Coombes", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Piccart", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Dowsett", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Bliss", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 14]]}, "event": {"name": "Abstracts: Thirty-Fifth Annual CTRC\u2010AACR San Antonio Breast Cancer Symposium\u2010\u2010 Dec 4\u20108, 2012; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS12-P2-14-01", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T18:46:58Z", "timestamp": 1558205218000}, "score": 41.48386, "issued": {"date-parts": [[2012, 12, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS12-P2-14-01"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs12-p2-14-01"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:29:30Z", "timestamp": 1574486970303}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 1, 15]]}, "DOI": "10.1158/0008-5472.sabcs-3038", "type": "proceedings-article", "created": {"date-parts": [[2010, 12, 30]], "date-time": "2010-12-30T23:31:29Z", "timestamp": 1293751889000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Novel non-steroidal p160 coactivator interactions in tamoxifen resistant breast cancer."], "prefix": "10.1158", "author": [{"given": "M", "family": "McIlroy", "sequence": "first", "affiliation": []}, {"given": "D", "family": "McCartan", "sequence": "additional", "affiliation": []}, {"given": "S", "family": "Early", "sequence": "additional", "affiliation": []}, {"given": "AD", "family": "Hill", "sequence": "additional", "affiliation": []}, {"given": "LS", "family": "Young", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 7]]}, "event": {"name": "CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS-3038", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T22:19:20Z", "timestamp": 1558217960000}, "score": 41.129677, "issued": {"date-parts": [[2009, 1, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS-3038"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs-3038"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}